
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Harnessing artificial intelligence to identify Bufalin as a molecular glue degrader of estrogen receptor alpha - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE532E758AF21EA3052E750002AFC145.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="ncomms">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373995/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Nature Communications">
<meta name="citation_title" content="Harnessing artificial intelligence to identify Bufalin as a molecular glue degrader of estrogen receptor alpha">
<meta name="citation_author" content="Shilong Jiang">
<meta name="citation_author_institution" content="Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China">
<meta name="citation_author_institution" content="The Hunan Institute of Pharmacy Practice and Clinical Research, Changsha, Hunan China">
<meta name="citation_author" content="Keyi Liu">
<meta name="citation_author_institution" content="Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China">
<meta name="citation_author" content="Ting Jiang">
<meta name="citation_author_institution" content="Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China">
<meta name="citation_author" content="Hui Li">
<meta name="citation_author_institution" content="Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China">
<meta name="citation_author" content="Xiao Wei">
<meta name="citation_author_institution" content="Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China">
<meta name="citation_author" content="Xiaoya Wan">
<meta name="citation_author_institution" content="Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China">
<meta name="citation_author" content="Changxin Zhong">
<meta name="citation_author_institution" content="Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China">
<meta name="citation_author" content="Rong Gong">
<meta name="citation_author_institution" content="Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China">
<meta name="citation_author" content="Zonglin Chen">
<meta name="citation_author_institution" content="Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China">
<meta name="citation_author_institution" content="Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan China">
<meta name="citation_author" content="Chan Zou">
<meta name="citation_author_institution" content="Center for Clinical Pharmacology, the Third Xiangya Hospital, Central South University, Changsha, China">
<meta name="citation_author" content="Qing Zhang">
<meta name="citation_author_institution" content="Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China">
<meta name="citation_author" content="Yan Cheng">
<meta name="citation_author_institution" content="Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China">
<meta name="citation_author_institution" content="Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, China">
<meta name="citation_author" content="Dongsheng Cao">
<meta name="citation_author_institution" content="Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China">
<meta name="citation_publication_date" content="2025 Aug 22">
<meta name="citation_volume" content="16">
<meta name="citation_firstpage" content="7854">
<meta name="citation_doi" content="10.1038/s41467-025-62288-7">
<meta name="citation_pmid" content="40846852">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373995/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373995/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373995/pdf/41467_2025_Article_62288.pdf">
<meta name="description" content="Target identification in natural products plays a critical role in the development of innovative drugs. Bufalin, a compound derived from traditional medicines, has shown promising anti-cancer activity; however, its precise molecular mechanism of ...">
<meta name="og:title" content="Harnessing artificial intelligence to identify Bufalin as a molecular glue degrader of estrogen receptor alpha">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Target identification in natural products plays a critical role in the development of innovative drugs. Bufalin, a compound derived from traditional medicines, has shown promising anti-cancer activity; however, its precise molecular mechanism of ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373995/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Searchâ€¦
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12373995">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s41467-025-62288-7"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41467_2025_Article_62288.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12373995%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12373995/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12373995/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373995/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-ncomms.gif" alt="Nature Communications logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Nature Communications" title="Link to Nature Communications" shape="default" href="http://www.nature.com/ncomms/index.html" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Nat Commun</button></div>. 2025 Aug 22;16:7854. doi: <a href="https://doi.org/10.1038/s41467-025-62288-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s41467-025-62288-7</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Nat%20Commun%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nat%20Commun%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Nat%20Commun%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Nat%20Commun%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Harnessing artificial intelligence to identify Bufalin as a molecular glue degrader of estrogen receptor alpha</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jiang%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Shilong Jiang</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Shilong Jiang</span></h3>
<div class="p">
<sup>1</sup>Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China </div>
<div class="p">
<sup>2</sup>The Hunan Institute of Pharmacy Practice and Clinical Research, Changsha, Hunan China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jiang%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shilong Jiang</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Keyi Liu</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Keyi Liu</span></h3>
<div class="p">
<sup>3</sup>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Keyi Liu</span></a>
</div>
</div>
<sup>3,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jiang%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Ting Jiang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Ting Jiang</span></h3>
<div class="p">
<sup>4</sup>Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jiang%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Ting Jiang</span></a>
</div>
</div>
<sup>4,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Hui Li</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Hui Li</span></h3>
<div class="p">
<sup>5</sup>Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hui Li</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wei%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Xiao Wei</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Xiao Wei</span></h3>
<div class="p">
<sup>5</sup>Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wei%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiao Wei</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wan%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Xiaoya Wan</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Xiaoya Wan</span></h3>
<div class="p">
<sup>4</sup>Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wan%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiaoya Wan</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhong%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Changxin Zhong</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Changxin Zhong</span></h3>
<div class="p">
<sup>4</sup>Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhong%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Changxin Zhong</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gong%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Rong Gong</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Rong Gong</span></h3>
<div class="p">
<sup>4</sup>Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gong%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rong Gong</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Zonglin Chen</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Zonglin Chen</span></h3>
<div class="p">
<sup>4</sup>Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China </div>
<div class="p">
<sup>6</sup>Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zonglin Chen</span></a>
</div>
</div>
<sup>4,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zou%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Chan Zou</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Chan Zou</span></h3>
<div class="p">
<sup>7</sup>Center for Clinical Pharmacology, the Third Xiangya Hospital, Central South University, Changsha, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zou%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chan Zou</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Q%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Qing Zhang</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Qing Zhang</span></h3>
<div class="p">
<sup>3</sup>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Q%22%5BAuthor%5D" class="usa-link"><span class="name western">Qing Zhang</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cheng%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Yan Cheng</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Yan Cheng</span></h3>
<div class="p">
<sup>4</sup>Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China </div>
<div class="p">
<sup>8</sup>Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cheng%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yan Cheng</span></a>
</div>
</div>
<sup>4,</sup><sup>8,</sup><sup>âœ‰</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cao%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Dongsheng Cao</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Dongsheng Cao</span></h3>
<div class="p">
<sup>5</sup>Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cao%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Dongsheng Cao</span></a>
</div>
</div>
<sup>5,</sup><sup>âœ‰</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China </div>
<div id="Aff2">
<sup>2</sup>The Hunan Institute of Pharmacy Practice and Clinical Research, Changsha, Hunan China </div>
<div id="Aff3">
<sup>3</sup>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China </div>
<div id="Aff4">
<sup>4</sup>Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China </div>
<div id="Aff5">
<sup>5</sup>Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China </div>
<div id="Aff6">
<sup>6</sup>Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan China </div>
<div id="Aff7">
<sup>7</sup>Center for Clinical Pharmacology, the Third Xiangya Hospital, Central South University, Changsha, China </div>
<div id="Aff8">
<sup>8</sup>Hunan Provincial Engineering Research Centre of Translational Medicine and Innovative Drug, Changsha, China </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>âœ‰</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Oct 1; Accepted 2025 Jul 13; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Â© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the articleâ€™s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the articleâ€™s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12373995Â Â PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40846852/" class="usa-link">40846852</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Target identification in natural products plays a critical role in the development of innovative drugs. Bufalin, a compound derived from traditional medicines, has shown promising anti-cancer activity; however, its precise molecular mechanism of action remains unclear. Here, we employ artificial intelligence, molecular docking, and molecular dynamics simulations to elucidate the molecular mechanism of Bufalin. Using an integrated multi-predictive strategy, we identify CYP17A1, ESR1, mTOR, AR, and PRKCD as the potential targets of Bufalin. Subsequent validation via surface plasmon resonance, biotin pulldown, and thermal shift assays confirms Bufalinâ€™s direct binding to ESR1, which encodes estrogen receptor alpha (ERÎ±). Molecular docking analyses pinpoint Bufalinâ€™s selective interaction with Arg394 on ERÎ±. Molecular dynamic simulations further show that Bufalin acts as a molecular glue, enhancing the interaction between ERÎ± and the E3 ligase STUB1, thereby promoting proteasomal degradation of ERÎ±. Given the therapeutic potential of ERÎ± degradation in overcoming endocrine resistance, we investigate the inhibitory effect of Bufalin on endocrine-resistant models and prove Bufalin reverses Tamoxifen resistance in vitro, in vivo, and in patient-derived breast cancer organoids from tamoxifen-relapsed cases. Collectively, our findings indicate that Bufalin functions as a molecular glue to degrade ERÎ±, offering a potential therapeutic strategy for reversing Tamoxifen resistance.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Subject terms:</strong> Targeted therapies, Drug development, Target identification</p></section></section><section class="abstract" id="Abs2"><hr class="headless">
<p id="Par2">Target identification of natural products plays a critical role in the development of innovative drugs. Here, this group integrates molecular docking and molecular dynamics simulations on Bufalin and reports the potential targets as well as its role in reversing endocrine resistance.</p></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par3">Natural products are the ideal starting points for molecular design and play a pivotal role in drug discovery. Identifying the specific targets of natural compounds is crucial for the development of innovative therapies. Bufalin, an active monomer extracted from the <em>Chansu</em>, is a potent anticancer agent used clinically in China to treat various cancers<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a></sup>. Accumulating evidence indicates that Bufalin exerts effective anti-tumor action against lung cancer, liver cancer, colorectal cancer, and glioma<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>,<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a></sup>. Recent studies have demonstrated that Bufalin inhibits tumor growth, regulates metastasis, and enhances antitumor immune responses by polarizing tumor-infiltrating macrophages toward the M1 phenotype<sup><a href="#CR2" class="usa-link" aria-describedby="CR2">2</a></sup>. However, the molecular mechanisms underlying Bufalinâ€™s anti-tumor activity remain to be elucidated. Current pharmacological research suggests that Bufalin could suppress multiple signaling pathways, including Hippo-YAP, Wnt/Î²-Catenin, JNK, SRC3/MIF, mTOR, and MAPK, leading to apoptosis, necrosis, and autophagy in different cancer cells<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>,<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>â€“<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a></sup>. Therefore, identifying Bufalinâ€™s exact anti-tumor targets is critical for optimizing its therapeutic applications.</p>
<p id="Par4">Target identification and validation in drug discovery are time-consuming and challenging procedures. Artificial intelligence (AI), which incorporates machine learning, deep learning, and network-based algorithms, has emerged as a powerful tool for predicting the potency, toxicity, and mechanism of action of compounds, thereby accelerating drug target discovery<sup><a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>,<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a></sup>. Previously, we developed a multi-scale system pharmacology (MSSP) method and a combinatorial target-screening strategy to explore drug-target interactions<sup><a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>,<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a></sup>. Recently, we established a fused multiple biological signature (FMBS) strategy to identify promising candidate targets<sup><a href="#CR13" class="usa-link" aria-describedby="CR13">13</a></sup>. However, the accurate identification of drug targets remains challenging.</p>
<p id="Par5">Estrogen receptors, including ERÎ± and ERÎ², are nuclear hormone receptors that mediate the effects of estrogen by regulating gene transcription through both signal transduction and transcription factor modulation. Among the subtypes of breast cancer, nearly 70%-80% of breast cancers are ER-positive (ER+)<sup><a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>â€“<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>. Active ER signaling promotes the proliferation and survival of ER+ breast cancer cells, with oncogenesis primarily mediated through ERÎ±, making it a key therapeutic target<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a></sup>. Endocrine therapies, including selective estrogen receptor modulators (SERMs) like Tamoxifen, selective estrogen receptor degraders (SERDs) like Fulvestrant, and aromatase inhibitors like Letrozole constitute frontline treatments for ER+ breastÂ cancer<sup><a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>â€“<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a></sup>. Among these agents, Tamoxifen, a selective estrogen receptor modulator, acts by competitively blocking the binding of estrogen to ERÎ± and has significantly improved prognosis in patients with ER+ breast cancer<sup><a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>,<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>,<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a></sup>. However, the therapeutic outcome of Tamoxifen is suboptimal due to the development of de novo or acquired resistance<sup><a href="#CR14" class="usa-link" aria-describedby="CR14">14</a></sup>. Approximately 30% of ER+ breast cancer cases recur with resistance to Tamoxifen, and this recurrence can lead to more aggressive neoplasms<sup><a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>,<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a></sup>. Therefore, exploring effective therapeutic strategies to reverse Tamoxifen resistance is imperative for ER+ breast cancer.</p>
<p id="Par6">In this study, we employ AI to predict the targets of Bufalin, and confirm that Bufalin could bind to ERÎ± and promote ERÎ± degradation. Mechanistic investigations reveal that Bufalin functions as a molecular glue, enhancing the interaction between ERÎ± and the ubiquitin E3 ligase STUB1, leading to the proteasomal degradation of ERÎ±. Based on this mechanism, we evaluate the efficacy of Bufalin against Tamoxifen-resistant breast cancer cells and find that Bufalin effectively overcomes resistance in vitro, in vivo and in patient-derived organoids. Our findings not only establish Bufalin as a molecular glue for degrading ERÎ± but also highlight its potential as a promising therapeutic candidate for the treatment of Tamoxifen-resistant breast cancer.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Exploring pharmacological mechanisms of Bufalin based on a combinatorial target screening strategy</h3>
<p id="Par7">We identified the potential targets of Bufalin by integrating target prediction methods, KEGG analysis, and multitask QSAR modeling with neural networks (Fig.Â <a href="#Fig1" class="usa-link">1a</a>). Initially, we employed the FMBS method along with four target prediction platforms, Swiss Target Prediction, SEA, PPB2, and ChEMBL33, to generate comprehensive and complementary prediction data (Fig.Â <a href="#Fig1" class="usa-link">1b</a>). To ensure the reliability of these initial predictions, we implemented intersection criteria that narrowed down the results to 53 candidate targets (Fig.Â <a href="#Fig1" class="usa-link">1b</a>). To further refine this target list and enhance the precision of our selection, KEGG enrichment analysis was conducted on 53 candidate targets (Fig.Â <a href="#Fig1" class="usa-link">1c</a>). We focused on the pathways that were statistically significant and specifically related to cancer and visualized these pathways using a chord diagram to highlight their associated targets, ultimately identifying 11 key targets (Fig.Â <a href="#Fig1" class="usa-link">1d</a>). Subsequently, we developed a Chemprop model<sup><a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup> trained on the 11-target datasets for systematic evaluation (Fig.Â <a href="#Fig1" class="usa-link">1e</a>). Using a default cutoff of 0.8, five target proteins were identified and marked as potential targets of Bufalin: CYP17A1, ESR1, mTOR, AR, and PRKCD. This multistage approach allowed for accurate prediction of Bufalinâ€™s mechanism, effectively guiding subsequent experimental validation.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1. Exploring pharmacological mechanisms of Bufalin based on a combinatorial target screening strategy.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373995_41467_2025_62288_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a08/12373995/c77aab3691d7/41467_2025_62288_Fig1_HTML.jpg" loading="lazy" id="d33e443" height="1000" width="708" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a</strong> The entire process of target prediction for Bufalin. <strong>b</strong> Venn diagram of predicted targets by four web servers and the FMBS method. <strong>c</strong> Bubble chart of KEGG enrichment analysis for 53 targets. <strong>d</strong> Chord diagram of pathways with statistically significant <em>p</em>-values and those corresponding to cancer, as retained by KEGG analysis. This diagram illustrates these pathways and their corresponding targets, leading to the selection of 11 key targets. <strong>e</strong> A multi-task neural network model was developed for these 11 targets, resulting in the identification of 5 high-confidence targets: CYP17A1, ESR1, mTOR, AR, and PRKCD.</p></figcaption></figure></section><section id="Sec4"><h3 class="pmc_sec_title">Bufalin directly interacts with estrogen receptor Î± (ERÎ±)</h3>
<p id="Par8">We then proceeded to experimentally validate the interaction between Bufalin and theÂ predicted targets. Given that the association of Bufalin with mTOR and AR has been previously reported<sup><a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>,<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a></sup>, we evaluated the binding of Bufalin to recombinant human ESR1, PRKCD, and CYP17A1 proteins using surface plasmon resonance (SPR) assays. As shown in Fig.Â <a href="#Fig2" class="usa-link">2aâ€“c</a>, SPR assays revealed that Bufalin exhibited the strongest binding affinity for ESR1 (encodes Estrogen Receptor Î±, ERÎ±) (KDâ€‰=â€‰5.42Eâˆ’06 M) compared to the PRKCD (PKC delta) (1.29Eâˆ’02 M) and CYP17A1 (2.94Eâˆ’02 M) (TableÂ <a href="#Tab1" class="usa-link">1</a>). To further confirm these findings, we synthesized Biotin-Bufalin conjugates, and found that Biotin-Bufalin specifically pulled down ERÎ± in biotin-pull down assays (Fig.Â <a href="#Fig2" class="usa-link">2d, e</a>). Moreover, the binding of Biotin-Bufalin with ERÎ± was dose-dependent (Fig.Â <a href="#Fig2" class="usa-link">2f</a>), and the addition of free Bufalin in cells significantly inhibited the binding of Biotin-Bufalin to ERÎ± (Fig.Â <a href="#Fig2" class="usa-link">2g</a>). Additionally, Bufalin increased the thermal stability of ERÎ± (Fig.Â <a href="#Fig2" class="usa-link">2h</a>), and the Biotin-Bufalin and ERÎ± were colocalized in the MCF-7 cells (Fig.Â <a href="#Fig2" class="usa-link">2i</a>). These results collectively demonstrate a specific and direct binding between Bufalin and the ERÎ± protein, supporting the potential of Bufalin as a targeted agent against ERÎ± in ER+ breast cancer.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2. Bufalin directly interacts with estrogen receptor Î± (ERÎ±).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373995_41467_2025_62288_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a08/12373995/88a947849ca3/41467_2025_62288_Fig2_HTML.jpg" loading="lazy" id="d33e516" height="1019" width="776" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>SPRi graph showing the interaction of Bufalin with ESR1 (<strong>a</strong>), PKC delta (<strong>b</strong>) and CYP17A1 (<strong>c</strong>) recombinant protein. <strong>d</strong> 293 T cell was transfected with ERÎ± plasmid, after transfected 48â€‰h, the cell lysates were incubated with D-Biotin or Biotin-Bufalin at 4â€‰Â°C overnight, followed by pulling-down with streptavidin magnetic beads. The proteins bound to the magnetic beads were separated by SDS-PAGE, followed by western blot using ERÎ± antibody. <strong>e</strong> MCF-7 cell lysates were incubated with D-Biotin or Biotin-Bufalin at 4â€‰Â°C overnight, followed by pulling-down with streptavidin magnetic beads. The proteins bound to the magnetic beads were separated by SDS-PAGE, followed by western blot using ERÎ± antibody. <strong>f</strong> 293â€‰T cell was transfected with ERÎ± plasmid, after transfected 48â€‰h, the cell lysates were incubated with a series of concentrations of Biotin-Bufalin at 4â€‰Â°C overnight, followed by pulling-down with streptavidin magnetic beads. The proteins bound to the magnetic beads were separated by SDS-PAGE, followed by western blot using ERÎ± antibody. <strong>g</strong> 293 T cell was transfected with Flag-ERÎ± plasmid, after transfected 48â€‰h, the cells were incubated with Bufalin, then the cell lysates were incubated with Biotin-Bufalin at 4â€‰Â°C, followed by pulling-down with streptavidin magnetic beads. The proteins bound to the magnetic beads were separated by SDS-PAGE, followed by western blot using Flag antibody. <strong>h</strong> The thermal shift assay experiment (CETSA) was used to evaluate the binding interaction between Bufalin and ERÎ±, the data are presented as meanâ€‰Â±â€‰SD, <em>n</em>â€‰=â€‰3 independent experiments. i. The cellular location of ERÎ± and Biotin-Bufalin was examined by immunofluorescence staining in MCF-7 cells (Scale bar 5Î¼m). Representative data are shown from <em>n</em>â€‰=â€‰3 independent experiments with consistent results.</p></figcaption></figure><section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>The kinetic parameters of Bufalin and ESR1, CYP17A1, and PKC delta binding from SPRi</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th colspan="1" rowspan="1">Protein</th>
<th colspan="1" rowspan="1">Avg ka (1/Ms)</th>
<th colspan="1" rowspan="1">Avg kd (1/s)</th>
<th colspan="1" rowspan="1">Avg KD (M)</th>
<th colspan="1" rowspan="1">ABS (tr_KD)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">ESR1</td>
<td align="left" colspan="1" rowspan="1">1.29Eâ€‰+â€‰02</td>
<td align="left" colspan="1" rowspan="1">6.98Eâˆ’04</td>
<td align="left" colspan="1" rowspan="1">5.42Eâˆ’06</td>
<td align="center" colspan="1" rowspan="1">17.492</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CYP17A1</td>
<td align="left" colspan="1" rowspan="1">2.50Eâ€‰+â€‰00</td>
<td align="left" colspan="1" rowspan="1">7.36Eâˆ’02</td>
<td align="left" colspan="1" rowspan="1">2.94Eâˆ’02</td>
<td align="center" colspan="1" rowspan="1">5.086</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PKC delta</td>
<td align="left" colspan="1" rowspan="1">1.79Eâ€‰+â€‰01</td>
<td align="left" colspan="1" rowspan="1">2.31Eâˆ’01</td>
<td align="left" colspan="1" rowspan="1">1.29Eâˆ’02</td>
<td align="center" colspan="1" rowspan="1">6.271</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec5"><h3 class="pmc_sec_title">Bufalin induces ERÎ± degradation and suppresses its transcriptional activity</h3>
<p id="Par9">To investigate the impact of Bufalin on ERÎ± protein levels, ER+ breast cancer cells were treated with various concentrations of Bufalin. Western blot analysis showed dose-dependent and time-dependent ERÎ± reduction upon Bufalin treatment (Fig.Â <a href="#Fig3" class="usa-link">3a, b</a>). Notably, the mRNA of ERÎ± had no obvious change in cells exposed to Bufalin, suggesting that the downregulation of the ERÎ± protein was not due to genetic transcription inhibition (Supplementary Fig.Â <a href="#MOESM1" class="usa-link">1a, b</a>).</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3. Bufalin induces ERÎ± degradation and suppresses its transcriptional activity.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373995_41467_2025_62288_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a08/12373995/b4b855eaad7a/41467_2025_62288_Fig3_HTML.jpg" loading="lazy" id="d33e635" height="1014" width="694" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a</strong> MCF-7 and T47D cells were treated with a series of concentrations of Bufalin for 48â€‰h, and the expression of ERÎ± was measured by western blot. <strong>b</strong> MCF-7 and T47D cells were treated with 50â€‰nM Bufalin for different periods of time, and the expression of ERÎ± was measured by western blot. <strong>c</strong> MCF-7 cells were treated with Bufalin, and then subjected to cycloheximide (CHX) (10â€‰Î¼g/ml) chase at the indicated time, the expression of ERÎ± was measured by western blot. Representative data are shown from nâ€‰=â€‰3 independent experiments with consistent results. <strong>d</strong> MCF-7 and T47D cells were treated with Bufalin for 48â€‰h with or without MG-132. The expression of ERÎ± was measured by western blot. <strong>e</strong> MCF-7 and T47D cells were treated with Bufalin for 48â€‰h in the presence or absence of MLN4924. The expression of ERÎ± was measured by western blot. <strong>f</strong> MCF-7 and T47D cells were treated with Bufalin in the presence or absence of hydroxychloroquine (HCQ). The expression of ERÎ± and LC3 was measured by western blot, the samples derive from the same experiment, and the gels/blots were processed in parallel. <strong>g</strong> 293 T cells were transfected with ERÎ± plasmid and HA-Ub plasmid, and then subjected to Bufalin for 48â€‰h, followed by treatment with MG-132 (10â€‰Î¼M) for 10â€‰hours before harvest. Then the cells lysates were subjected immunoprecipitation with anti-ERÎ± antibodies and blotted with anti-HA antibodies. <strong>h</strong> 293â€‰T cells were transfected with Flag-ERÎ± plasmid, and then subjected to Bufalin for 48â€‰h, followed by treatment with MG-132 (10â€‰Î¼M) for 10â€‰hours before harvest. Then the cells lysates were subjected immunoprecipitation with anti-Flag antibodies and blotted with anti-Ub antibodies. <strong>i</strong> ERE-luciferase assay after Bufalin treatment, the data are presented as meanâ€‰Â±â€‰SD, <em>n</em>â€‰=â€‰3 independent experiments. Two-way ANOVA was used for statistical analysis, <em>P</em>â€‰&lt;â€‰0.05 was considered to be statistically significant. <strong>j</strong> MCF-7 cells were treated with a series of concentrations of Bufalin for 48â€‰h in the presence or absence of E2, the mRNA levels of AGR2, CCND1, GREB1, NRIP1, PGR, and SIAH2 were analyzed by real-time PCR, the data are presented as meanâ€‰Â±â€‰SD, <em>n</em>â€‰=â€‰3 independent experiments. Two-way ANOVA was used for statistical analysis, <em>P</em>â€‰&lt;â€‰0.05 was considered to be statistically significant.</p></figcaption></figure><p id="Par10">To further validate that Bufalin functions as an ERÎ± protein degrader, we conducted cycloheximide (CHX) chase assays. The results demonstrated that Bufalin combined with CHX significantly accelerated the degradation of ERÎ± (Fig.Â <a href="#Fig3" class="usa-link">3c</a>). Furthermore, treatment with the proteasome inhibitor MG-132 effectively prevented the Bufalin-induced decrease in ERÎ± protein levels (Fig.Â <a href="#Fig3" class="usa-link">3d</a>). We also examined ERÎ± expression following treatment with Bufalin alongside the E1 ubiquitin-activating enzyme inhibitor MLN4924. As illustrated in Fig.Â <a href="#Fig3" class="usa-link">3e</a>, MLN4924 reversed the Bufalin-mediated downregulation of ERÎ±. In contrast, the lysosomal inhibitor hydroxychloroquine (HCQ) failed to rescue ERÎ± levels (Fig.Â <a href="#Fig3" class="usa-link">3f</a>). Additionally, co-immunoprecipitation (Co-IP) assays revealed enhanced ubiquitination of ERÎ± in response to Bufalin treatment (Fig.Â <a href="#Fig3" class="usa-link">3g, h</a>), corroborating that Bufalin induces ERÎ± degradation predominantly through the proteasomal pathway.</p>
<p id="Par11">Upon ligand binding, ERÎ± undergoes dimerization and attaches to estrogen response elements (EREs) within the promoter regions of estrogen-responsive genes, thereby promoting their transcription<sup><a href="#CR28" class="usa-link" aria-describedby="CR28">28</a></sup>. As results thus far demonstrated that Bufalin could degrade ERÎ±, we next assessed whether the transcriptional actions of ERÎ± were impaired by Bufalin. The ERE luciferase assay showed that Bufalin weakened the transcriptional activity of ERÎ± (Fig.Â <a href="#Fig3" class="usa-link">3i</a>), which was corroborated by downregulation of ERÎ± target genes, including AGR2, CCND1, GREB1, NRIP1, PGR, and SIAH2 (Fig.Â <a href="#Fig3" class="usa-link">3j</a> and Supplementary Fig.Â <a href="#MOESM1" class="usa-link">1c</a>).</p>
<p id="Par12">Fulvestrant is currently the FDA-approved selective estrogen receptor degrader (SERD) that induces proteasomal degradation of ERÎ± for the treatment of ER + breast cancer<sup><a href="#CR29" class="usa-link" aria-describedby="CR29">29</a></sup>. Considering that Bufalin and Fulvestrant share a similar mechanism targeting ERÎ±, we then compared the effects of each compound on ERÎ± degradation. The results showed that Bufalin had a superior ERÎ± degradation efficacy compared to that of Fulvestrant (Supplementary Fig.Â <a href="#MOESM1" class="usa-link">1d</a>). In addition, Bufalin exhibited stronger anti-cancer effects than Fulvestrant (Supplementary Fig.Â <a href="#MOESM1" class="usa-link">1eâ€“g</a>). These findings highlight Bufalin as a promising therapeutic candidate with dual advantages in ERÎ± degradation potency and anti-cancer activity.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Bufalin selectively binds to Arg394 (R394) of ERÎ±</h3>
<p id="Par13">Next, we want to investigate the binding site of Bufalin on the protein structure of ERÎ±. First, the Glide SP protocol was used to dock Bufalin into the binding pocket of ESR1 (Fig.Â <a href="#Fig4" class="usa-link">4a</a>). The docked structure of the ESR1-Bufalin complex was then subjected to 100â€‰ns molecular dynamics simulations with Amber22 software, followed by MM-GBSA energy calculations and residue energy decomposition. The top 10 residues identified from MM-GBSA energy decomposition (Fig.Â <a href="#Fig4" class="usa-link">4b</a>) were further analyzed using alanine scanning mutagenesis (Fig.Â <a href="#Fig4" class="usa-link">4c</a>). Our analysis revealed that residues with energy contributions better than âˆ’1 kcal/mol, specifically Leu354, Leu387, Arg394, Met528, and Ala350, are key residues for Bufalin binding to ERÎ±.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4. Bufalin selectively binds to Arg394 (R394) of ERÎ±.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373995_41467_2025_62288_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a08/12373995/475bc25cd5eb/41467_2025_62288_Fig4_HTML.jpg" loading="lazy" id="d33e718" height="992" width="790" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a</strong> Bufalin was docked into the binding pocket of ESR1 using the Glide SP protocol. <strong>b</strong> The docked structure of the ESR1-Bufalin complex was then subjected to 100â€‰ns of molecular dynamics simulations using Amber, followed by MM-GBSA energy calculations and residue energy decomposition. The top 10 residues from the MM-GBSA residue energy decomposition scoring. <strong>c</strong> The top 10 residues selected for alanine scanning mutagenesis. Error values were derived from energy snapshots based on 100 frames uniformly extracted from the last 100â€‰ns of the MD simulation trajectory. <strong>d</strong> 293â€‰T cell was transfected with ERÎ± wild type (WT) plasmid or mutant plasmid, after transfected 48â€‰h, the cell lysates were incubated with Biotin-Bufalin at 4â€‰Â°C overnight, followed by pulling-down with streptavidin magnetic beads. The proteins bound to the magnetic beads were separated by SDS-PAGE, followed by western blot using ERÎ± antibody. <strong>e</strong> 293â€‰T cells were transfected with ERÎ± WT or mutant plasmid, followed by treatment with Bufalin for 48â€‰h. The ERÎ± protein levels were measured by western blot. <strong>f</strong> 293â€‰T cells were transfected with Flag-ERÎ± WT or R394A mutant plasmid and HA-Ub plasmid, and then subjected to Bufalin for 48â€‰h, followed by treatment with MG-132 (10â€‰Î¼M) for 10â€‰hours before harvest. Then the cells lysates were subjected immunoprecipitation with anti-Flag antibodies and blotted with anti-HA antibodies.</p></figcaption></figure><p id="Par14">To experimentally validate these computational findings, we generated mutant plasmids of ERÎ±, each containing a single amino acid substitution (Leu354, Leu387, Arg394, Met528, or Ala350) with alanine or glutamine. The wild-type (WT) and mutant ERÎ± plasmids were transfected into 293â€‰T cells. The cell lysates were incubated with Biotin-Bufalin and subjected to pull-down experiments using streptavidin-magnetic beads. The results showed that only the ERÎ± Arg394A mutant lost the ability to bind Biotin-Bufalin, while the other mutants retained similar binding affinities to Biotin-Bufalin compared to WT ERÎ± (Fig.Â <a href="#Fig4" class="usa-link">4d</a>). Furthermore, the degradation efficacy of Bufalin on the ERÎ± Arg394A protein was significantly reduced (Fig.Â <a href="#Fig4" class="usa-link">4e</a>). Co-IP experiments indicated a decrease in ubiquitination of the ERÎ± Arg394A mutant compared to the WT protein in the presence of Bufalin (Fig.Â <a href="#Fig4" class="usa-link">4f</a>). These findings indicate that the Arg394 residue of ERÎ± is critical for the binding interaction between ERÎ± and Bufalin, underscoring its importance in Bufalin-mediated ERÎ± degradation.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Bufalin facilitates ERÎ± degradation by enhancing interaction between ERÎ± and the E3 ligase STUB1</h3>
<p id="Par15">Next, we investigated the molecular mechanism underlying Bufalin-induced ERÎ± degradation. Based on the established role in the ERÎ±-degradation pathway, we employed molecular dynamics simulation analysis to determine whether Bufalin could influence the interaction between ERÎ± and ubiquitin ligase including TRIM56, RNF181, RNF2, and STUB1. It has been reported that the ubiquitin ligases TRIM56, RNF181, and RNF2 stabilize ERÎ± expression<sup><a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>â€“<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a></sup>. On the contrary, the ubiquitin ligase STUB1 downregulates ERÎ± levels through the ubiquitinâ€“proteasome system<sup><a href="#CR33" class="usa-link" aria-describedby="CR33">33</a></sup>. Our results showed the binding free energy between ERÎ± and STUB1 was changed from âˆ’4.9455â€‰kcal/mol to âˆ’58.1918 kcal/mol owing to the involvement of Bufalin (Supplementary TableÂ <a href="#MOESM1" class="usa-link">1</a>), consistent with the experimental results. STUB1 contains a TPR domain that specifically recognizes and binds to molecular chaperone proteins HSP70/HSP90, with ERÎ± being a classic component of this chaperone system. Moreover, STUB1 expression is closely associated with breast cancer prognosis. Previous studies have established STUB1 as a key mediator in ERÎ± degradation<sup><a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>â€“<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a></sup>. The Fig.Â <a href="#Fig5" class="usa-link">5a</a> illustrates the binding poses of ERÎ± and STUB1 with Bufalin: the protein-protein docking result (magenta), the clustered conformation after 200â€‰ns MD simulation with Bufalin (green), and the clustered conformation after 200â€‰ns MD simulation without Bufalin (blue). Detailed structural analysis of the 200â€‰ns simulation trajectory reveals that Bufalin repositions itself deeper within the ERÎ± binding pocket, forming a hydrogen bond with Arg394 of ERÎ± (Fig.Â <a href="#Fig5" class="usa-link">5b</a>). This repositioning appears to induce subtle conformational changes in ERÎ± that enhance its binding interface with STUB1. RMSD analysis demonstrates that the ERÎ±-STUB1 complex remains conformationally stable throughout the 200â€‰ns simulation in the presence of Bufalin (Fig.Â <a href="#Fig5" class="usa-link">5c</a>). This finding is further supported by the binding surface area analysis (Fig.Â <a href="#Fig5" class="usa-link">5d</a>), which shows enhanced interaction between ERÎ± and STUB1 when Bufalin is present. Moreover, RMSF profiles of ESR1 and STUB1 indicate that ligand binding reduces the flexibility of residues at the protein-protein interface. Specifically, decreased fluctuations were observed in residues 335â€“343, 417â€“425, and 515â€“538 of ESR1, and in residues 25â€“49, 61â€“69, and 121â€“136 of STUB1 (Fig.Â <a href="#Fig5" class="usa-link">5e</a>). As the simulation progressed, the presence of Bufalin also resulted in an increased number of hydrogen bonds between STUB1 and ESR1, further stabilizing their interaction (Fig.Â <a href="#Fig5" class="usa-link">5f</a>).</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5. Bufalin facilitates ERÎ± degradation by enhancing interaction between ERÎ± and the E3 ligase STUB1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373995_41467_2025_62288_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a08/12373995/08fc1f2a3efa/41467_2025_62288_Fig5_HTML.jpg" loading="lazy" id="d33e809" height="1015" width="730" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a</strong> The binding poses of ERÎ± and STUB1 with or without Bufalin. The magenta structure represents the result of protein-protein docking, the green structure corresponds to the clustered conformation after a 200â€‰ns MD simulation with Bufalin, and the blue structure represents the clustered conformation after a 200â€‰ns MD simulation without Bufalin. Bufalin is shown as yellow sticks in the structural representation. <strong>b</strong> The conformational changes of the ERÎ±-Bufalin-STUB1 complex at 200â€‰ns. <strong>c</strong> RMSD plots of the ERÎ±-STUB1 complex over 200â€‰ns of MD simulation with or without Bufalin. <strong>d</strong> The binding surface area analysis between ERÎ± and STUB1 with or without Bufalin. <strong>e</strong> RMSF (root-mean-square fluctuation) profiles of ERÎ± and STUB1 with or without Bufalin. <strong>f</strong> Changes in the number of H-bonds throughout the simulation between ERÎ± and STUB1 with or without Bufalin. <strong>g</strong> MCF-7 and T47D cell was transfected with nontargeting siRNA or STUB1-targeted siRNA, the expression of ERÎ± and STUB1 were measured by western blot, the samples derive from the same experiment and that gels/blots were processed in parallel. <strong>h</strong> 293â€‰T cells transfected with Flag-ERÎ± and HA-STUB1 plasmid were treated by Bufalin, then lysed and lysates were subjected immunoprecipitation with anti-Flag antibodies. Proteins retained on sepharose were blotted with the indicated antibodies. The input samples derive from the same experiment, and that gels/blots were processed in parallel. <strong>i</strong> MCF-7 and T47D cells were transfected with nontargeting siRNA or STUB1-targeted siRNA followed by treatment with Bufalin for 48â€‰h. The ERÎ± and STUB1 protein levels were measured by Western blot.</p></figcaption></figure><p id="Par16">Subsequently, we sought to examine the binding between ERÎ± and STUB1 after treatment with Bufalin. Consistent with previously published research, silencing STUB1 increased ERÎ± levels (Fig.Â <a href="#Fig5" class="usa-link">5g</a>). To determine whether STUB1 participates in Bufalin-induced ERÎ± ubiquitination and degradation, we conducted co-immunoprecipitation (Co-IP) assays to assess the interaction between ERÎ± and STUB1. The results showed that Bufalin enhanced the binding of ERÎ± and STUB1 (Fig.Â <a href="#Fig5" class="usa-link">5h</a>). Furthermore, STUB1 knockdown attenuated Bufalin-induced ERÎ± degradation (Fig.Â <a href="#Fig5" class="usa-link">5i</a>), suggesting that STUB1 was required for ubiquitination of ERÎ± induced by Bufalin. Collectively, these findings suggest that Bufalin functions as a molecular glue, facilitating the interaction between ERÎ± and STUB1 and thereby inducing proteasomal degradation of ERÎ±.</p></section><section id="Sec8"><h3 class="pmc_sec_title">Bufalinâ€™s anti-cancer effects in ER+ cells are dependent on ERÎ±</h3>
<p id="Par17">To further elucidate the connection between Bufalin-mediated anti-cancer activity and ERÎ± levels in ER+ breast cancer cells, we assessed Bufalinâ€™s impacts on cell proliferation and apoptosis. Bufalin significantly inhibited MCF-7 and T47D cells growth, as demonstrated by both colony formation and CCK-8 assays (Fig.Â <a href="#Fig6" class="usa-link">6a, b</a>). Additionally, treatment with Bufalin induced apoptosis, as evidenced by the elevated Annexin V-positive populations (Fig.Â <a href="#Fig6" class="usa-link">6c</a>).</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6. Bufalinâ€™s anti-cancer effects in ER+ cells are dependent on ERÎ±.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373995_41467_2025_62288_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a08/12373995/8b660697f112/41467_2025_62288_Fig6_HTML.jpg" loading="lazy" id="d33e904" height="1016" width="726" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a</strong> The colony formation assay was used to measure MCF-7 and T47D cell proliferation after treatment by Bufalin, the data are presented as meanâ€‰Â±â€‰SD, nâ€‰=â€‰3 independent experiments. One-way ANOVA was used for statistical analysis, <em>P</em>â€‰&lt;â€‰0.05 was considered to be statistically significant. <strong>b</strong> MCF-7 and T47D cells were treated with a series of concentrations of Bufalin, and cell viability was determined using the CCK-8 assay, the data are presented as meanâ€‰Â±â€‰SD, nâ€‰=â€‰3 independent experiments. One-way ANOVA was used for statistical analysis, <em>P</em>â€‰&lt;â€‰0.05 was considered to be statistically significant. <strong>c</strong> MCF-7 cells were treated with 20 or 50â€‰nM Bufalin for 48â€‰h, and the apoptosis was examined by measuring Annexin V staining, the data are presented as meanâ€‰Â±â€‰SD, <em>n</em>â€‰=â€‰3 independent experiments. One-way ANOVA was used for statistical analysis, <em>P</em>â€‰&lt;â€‰0.05 was considered to be statistically significant. <strong>d</strong>, <strong>e</strong> MCF-7 cells were transfected with nontargeting siRNA or ESR1 siRNA followed by treatment with Bufalin for 48â€‰h, and apoptosis was examined by measuring Annexin V staining, the data are presented as meanâ€‰Â±â€‰SD, <em>nâ€‰</em>=â€‰3 independent experiments. One-way ANOVA was used for statistical analysis, <em>P</em>â€‰&lt;â€‰0.05 was considered to be statistically significant. <strong>f</strong> MCF-7 cells were transfected with nontargeting siRNA or ESR1 siRNA followed by treatment with Bufalin for 48â€‰h, and the ERÎ± and PARP protein levels were measured by western blot, the samples derive from the same experiment and that gels/blots were processed in parallel. <strong>g</strong> T47D cells were transfected with nontargeting siRNA or ESR1 siRNA followed by treatment with Bufalin, and the cell viability was determined using the CCK-8 assay, the data are presented as meanâ€‰Â±â€‰SD, <em>n</em>â€‰=â€‰3 independent experiments. Two-way ANOVA was used for statistical analysis, <em>P</em>â€‰&lt;â€‰0.05 was considered to be statistically significant. <strong>h</strong> 293â€‰T cells were transfected with Flag-ERÎ± plasmid followed by treatment with Bufalin, and the cell viability was determined using the CCK-8 assay, the data are presented as meanâ€‰Â±â€‰SD, <em>n</em>â€‰=â€‰3 independent experiments. Two-way ANOVA was used for statistical analysis, <em>P</em>â€‰&lt;â€‰0.05 was considered statistically significant. <strong>i</strong> MCF-7 cells were transfected with nontargeting siRNA or ESR1 siRNA followed by treatment with Bufalin, and the colony formation assay was used to measure cell proliferation, the data are presented as meanâ€‰Â±â€‰SD, <em>n</em>â€‰=â€‰3 independent experiments. One-way ANOVA was used for statistical analysis, <em>P</em>â€‰&lt;â€‰0.05 was considered to be statistically significant.</p></figcaption></figure><p id="Par18">To determine if Bufalinâ€™s anti-tumor effects are linked to ERÎ± expression, ERÎ±-knockdown models revealed a diminished therapeutic response to Bufalin, as indicated by decreased Annexin V staining (Fig.Â <a href="#Fig6" class="usa-link">6d, e</a>). Moreover, ERÎ± silencing attenuated Bufalin-induced apoptosis, which was confirmed by the reduced expression of cleaved PARP (Fig.Â <a href="#Fig6" class="usa-link">6f</a>). We also observed that silencing ERÎ± expression diminished Bufalinâ€™s anti-cancer effects on breast cancer cells (Fig.Â <a href="#Fig6" class="usa-link">6g</a>), whereas cells overexpressing ERÎ± were more sensitive to Bufalin (Fig.Â <a href="#Fig6" class="usa-link">6h</a>). Consistently, colony formation assays demonstrated that cells with silenced ERÎ± were less sensitive to Bufalin treatment compared to control cells (Fig.Â <a href="#Fig6" class="usa-link">6i</a>). These findings suggest that the anti-tumor activity of Bufalin mechanistically depends on ERÎ± degradation, identifying ERÎ± as the critical therapeutic target of Bufalin.</p></section><section id="Sec9"><h3 class="pmc_sec_title">Bufalin overcomes Tamoxifen resistance in vitro and in vivo</h3>
<p id="Par19">It has been reported that persistent ERÎ± expression post-Tamoxifen therapy motivates SERD development, such as Fulvestrant, which improved clinical benefits after failure of other endocrine therapies<sup><a href="#CR36" class="usa-link" aria-describedby="CR36">36</a></sup>. Given the ERÎ±-degradation capacity of Bufalin, we investigated Bufalin potential against endocrine resistance. Clinical samples from endocrine therapy-relapsed patients (<em>n</em>â€‰=â€‰8) maintained ERÎ± expression (Fig.Â <a href="#Fig7" class="usa-link">7a</a>). We next examined the ERÎ± proteasomal degradation by Bufalin in Tamoxifen resistance cell LCC2. As shown in Fig.Â <a href="#Fig7" class="usa-link">7b</a>, the Bufalin could promote the ERÎ± degradation in Tamoxifen-resistant cell LCC2, which suggested that the Tamoxifen-treated relapsed patient may benefit from Bufalin treatment. As shown in Fig.Â <a href="#Fig7" class="usa-link">7c</a>, Bufalin treatment reduced the viability of LCC2 cells in a dose-dependent manner, with colony formation and EdU assays further confirming its inhibitory effect on cell proliferation (Fig.Â <a href="#Fig7" class="usa-link">7d, e</a>). Additionally, the activation of apoptosis induced by Bufalin was evidenced by increased Annexin V staining, PARP cleavage, and Bcl-2 downregulation in LCC2 cells (Fig.Â <a href="#Fig7" class="usa-link">7f, g</a>). Moreover, Bufalin exhibited better anti-cancer effects than Fulvestrant against LCC2 cells (Fig.Â <a href="#Fig7" class="usa-link">7h, i</a>).</p>
<figure class="fig xbox font-sm" id="Fig7"><h4 class="obj_head">Fig. 7. Bufalin overcomes Tamoxifen resistance in vitro.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373995_41467_2025_62288_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a08/12373995/8decc01eb7eb/41467_2025_62288_Fig7_HTML.jpg" loading="lazy" id="d33e1019" height="1005" width="700" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a</strong> Representative IHC staining for ERÎ± in Tamoxifen treatment relapsed simple (Scale bar 20Î¼m). <strong>b</strong> Tamoxifen-resistant cells LCC2 were treated with a serious of Bufalin, the expression of ERÎ± was measured by western blot. <strong>c</strong> Tamoxifen-resistant cells LCC2 were treated with Bufalin, and cell viability was determined using the CCK-8 assay, the data are presented as meanâ€‰Â±â€‰SD, nâ€‰=â€‰3 independent experiments. One-way ANOVA was used for statistical analysis, <em>P</em>â€‰&lt;â€‰0.05 was considered statistically significant. <strong>d</strong> The colony formation assay was used to measure LCC2 cell proliferation after treatment by Bufalin, the data are presented as meanâ€‰Â±â€‰SD, nâ€‰=â€‰3 independent experiments. One-way ANOVA was used for statistical analysis, <em>P</em>â€‰&lt;â€‰0.05 was considered to be statistically significant. <strong>e</strong> The EdU assay was used to measure LCC2 cell proliferation following treatment with Bufalin (Scale bar 100Î¼m), the data are presented as meanâ€‰Â±â€‰SD, <em>n</em>â€‰=â€‰3 independent experiments. One-way ANOVA was used for statistical analysis, <em>P</em>â€‰&lt;â€‰0.05 was considered statistically significant. <strong>f</strong> LCC2 cells were treated with 50 or 100â€‰nM Bufalin for 48â€‰h, and the expression of PARP and Bcl-2 was measured by western blot, the samples derive from the same experiment and that gels/blots were processed in parallel. <strong>g</strong> LCC2 cells were treated with 50 or 100â€‰nM Bufalin for 48â€‰h, and apoptosis was examined by measuring Annexin V staining, the data are presented as meanâ€‰Â±â€‰SD, <em>n</em>â€‰=â€‰3 independent experiments. One-way ANOVA was used for statistical analysis, <em>P</em>â€‰&lt;â€‰0.05 was considered statistically significant. <strong>h</strong> The colony formation assay was used to measure LCC2 cell proliferation after treatment with Bufalin or Fulvestrant, the data are presented as meanâ€‰Â±â€‰SD, <em>n</em>â€‰=â€‰3 independent experiments. One-way ANOVA was used for statistical analysis, <em>P</em>â€‰&lt;â€‰0.05 was considered statistically significant. <strong>i</strong> Tamoxifen-resistant cells LCC2 were treated with Bufalin and Fulvestrant, and cell viability was determined using the CCK-8 assay, the data are presented as meanâ€‰Â±â€‰SD, <em>n</em>â€‰=â€‰3 independent experiments. Two-way ANOVA was used for statistical analysis, <em>P</em>â€‰&lt;â€‰0.05 was considered statistically significant.</p></figcaption></figure><p id="Par20">To validate the efficacy of Bufalin against Tamoxifen resistance in vivo, we established Tamoxifen-resistant LCC2 xenografts. As shown in Fig.Â <a href="#Fig8" class="usa-link">8aâ€“c</a>, following intraperitoneal injection of Bufalin, the tumor volumes and weights significantly decreased, demonstrating superior anti-tumor activity to Fulvestrant. Immunohistochemical analysis revealed marked Ki67 suppression in Bufalin-treated tumors (Fig.Â <a href="#Fig8" class="usa-link">8d</a>). H&amp;E staining revealed that xenograft tumor cells treated with Bufalin appeared more loosely arranged and exhibited smaller nuclei compared to those in the vehicle-treated group (Fig.Â <a href="#Fig8" class="usa-link">8e</a>). Moreover, the protein expression of ERÎ± was decreased in tumors following Bufalin treatment (Fig.Â <a href="#Fig8" class="usa-link">8f, g</a>). To evaluate potential toxicity, we analyzed various serum biochemical markers related to liver and kidney function in mice, and found no significant signs of drug-induced toxicity at the therapeutic doses of Bufalin (Fig.Â <a href="#Fig8" class="usa-link">8h, i</a>), suggesting a favorable safety profile. Taken together, these results indicate that Bufalin acts as a molecular glue-type ERÎ± degrader that effectively overcomes Tamoxifen resistance in preclinical models.</p>
<figure class="fig xbox font-sm" id="Fig8"><h4 class="obj_head">Fig. 8. Bufalin overcomes Tamoxifen resistance in vivo.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373995_41467_2025_62288_Fig8_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a08/12373995/2011959cb5d9/41467_2025_62288_Fig8_HTML.jpg" loading="lazy" id="d33e1096" height="1017" width="780" alt="Fig. 8"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>4-week-old female nude mice were inoculated with LCC2 cells. The tumor-bearing mice were subsequently given the indicated treatment (<em>n</em>â€‰=â€‰7 mice per group). <strong>a</strong> Subcutaneous tumors were excised and photographed at the end of the experiment. <strong>b</strong> Tumor sizes were measured on the specified days, the data are presented as meanâ€‰Â±â€‰SD, <em>n</em>â€‰=â€‰7 mice. One-way ANOVA was used for statistical analysis, <em>P</em>â€‰&lt;â€‰0.05 was considered to be statistically significant. <strong>c</strong> Tumor weights were measured at the end of the experiments, the data are presented as meanâ€‰Â±â€‰SD, <em>n</em>â€‰=â€‰7 mice. One-way ANOVA was used for statistical analysis, <em>P</em>â€‰&lt;â€‰0.05 was considered to be statistically significant. <strong>d</strong> Representative IHC images for detecting Ki67 expression in the tumor specimens (Scale bar 20Î¼m). <strong>e</strong> Representative histological analysis of tumor specimen stained by H&amp;E (Scale bar 20Î¼m). <strong>f</strong> Representative IHC images for detecting ERÎ± expression in the tumor specimens (Scale bar 20Î¼m). <strong>g</strong> Western blot analysis of the ERÎ± protein expression in xenografts following the indicated treatment. <strong>h</strong>, <strong>i</strong> Mice liver and kidney functions were measured at the end of the experiments, the data are presented as meanâ€‰Â±â€‰SD, <em>n</em>â€‰=â€‰7 mice. One-way ANOVA was used for statistical analysis, <em>P</em>â€‰&lt;â€‰0.05 was considered to be statistically significant (Vehicle vs. Buf (0.5â€‰mg/kg), Vehicle vs. Buf (1.0â€‰mg/kg), Vehicle vs. Ful (2.0â€‰mg/kg)). Buf Bufalin, Ful Fulvestrant.</p></figcaption></figure></section><section id="Sec10"><h3 class="pmc_sec_title">Bufalin exerts significant anti-cancer activity in Tamoxifen-resistant patient-derived organoids</h3>
<p id="Par21">To further evaluate the therapeutic potential of Bufalin in a clinically relevant setting, we established Tamoxifen-resistant patient-derived organoids (PDOs) from relapsed breast cancer specimens. As shown in Fig.Â <a href="#Fig9" class="usa-link">9a</a>, PDOs were successfully established from Tamoxifen-resistant patient specimens, and treatment with Bufalin resulted in a significant reduction in the size of these organoids, indicating its potent inhibitory effect on the growth of Tamoxifen-resistant tumors (Fig.Â <a href="#Fig9" class="usa-link">9b</a>). Additionally, the Tamoxifen-resistant PDOs showed a marked decrease in cell viability after Bufalin treatment (Fig.Â <a href="#Fig9" class="usa-link">9c</a>). Calcein-AM/PI fluorescence staining further revealed extensive cell death in the Bufalin-treated organoids (Fig.Â <a href="#Fig9" class="usa-link">9d</a>). These results underscore the potential of Bufalin as an effective therapeutic agent for Tamoxifen resistance in ER+ breast cancer and validate its translational potential in cancer therapy.</p>
<figure class="fig xbox font-sm" id="Fig9"><h4 class="obj_head">Fig. 9. Bufalin exerts significant anti-cancer activity in Tamoxifen-resistant patient-derived organoids.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373995_41467_2025_62288_Fig9_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a08/12373995/e76244c51bbe/41467_2025_62288_Fig9_HTML.jpg" loading="lazy" id="d33e1151" height="730" width="700" alt="Fig. 9"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig9/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a</strong> Representative images of Tamoxifen treatment relapsed patient-derived organoids after treatment by Bufalin (Scale bar 50 Î¼m). Representative data are shown from nâ€‰=â€‰3 independent experiments with consistent results. <strong>b</strong> Statistics of tumor organoid size of formed organoids after Bufalin treatment, the data are presented as meanâ€‰Â±â€‰SD, <em>n</em>â€‰=â€‰3 independent experiments. One-way ANOVA was used for statistical analysis, <em>P</em>â€‰&lt;â€‰0.05 was considered statistically significant. <strong>c</strong> The proliferation of Tamoxifen treatment relapsed patient-derived organoids treated with Bufalin, the data are presented as meanâ€‰Â±â€‰SD, <em>n</em>â€‰=â€‰3 independent experiments. One-way ANOVA was used for statistical analysis, <em>P</em>â€‰&lt;â€‰0.05 was considered statistically significant. <strong>d</strong> The growth inhibition of Bufalin was demonstrated by Calcein-AM/PI fluorescence staining of PDO (Scale bar 50Î¼m). BF: bright field. Representative data are shown from <em>n</em>â€‰=â€‰3 independent experiments with consistent results. <strong>e</strong> Schematic of the proposed mechanism of Bufalin in ER-positive breast cancer. This study harnessed artificial intelligence combined with molecular docking to predict the molecular mechanism of Bufalin against tumor. Bufalin could bind to ERÎ± and increase the interaction between ERÎ± and the ubiquitin E3 ligase STUB1, leading to the degradation of ERÎ±. Additionally, Bufalin could overcome Tamoxifen resistance in vitro and in vivo.</p></figcaption></figure></section></section><section id="Sec11"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par22">Bufalin has emerged as a clinically validated natural compound with therapeutic potential across multiple cancer types. Mechanistic studies reveal its pleiotropic anti-tumor effects through cancer-type-specific targets<sup><a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>,<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a></sup>. Accordingly, identifying the molecular targets of Bufalin is pivotal for advancing drug development and repurposing efforts. To this end, various computational models for target prediction have been developed, leading to notable improvements in predictive accuracy and efficiency<sup><a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>â€“<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a></sup>. Our prior work has successfully developed a variety of strategies to predict drug targets by integrating multiple biological signatures<sup><a href="#CR13" class="usa-link" aria-describedby="CR13">13</a></sup>, and successfully discovered the target of Ixabepilone, Mitoxantrone, and Tubeimoside-1 are Bcl-2, eEF2K, and AKT, respectively<sup><a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>,<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>,<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a></sup>. In this study, we applied an integrated multi-predictive strategy and identified CYP17A1, ESR1, mTOR, AR, and PRKCD as potential targets of Bufalin, with experimental validation confirming ERÎ± (ESR1) as the primary target in ER+ breast cancer, offering a strategy for clinical application. Molecular docking experiments revealed that Bufalin selectively binds to R394 of ERÎ±, while molecular dynamics simulations suggest its molecular glue function stabilizes the interaction between ERÎ± and STUB1, leading to ERÎ± degradation and overcoming endocrine resistance (Fig.Â <a href="#Fig9" class="usa-link">9e</a>). This integrative AI strategy establishes a robust paradigm for natural product target discovery and mechanistic elucidation.</p>
<p id="Par23">Bufalin has been reported to inhibit key signaling pathways such as mTOR, Wnt/Î²-catenin, and Akt, which are necessary for cancer cell survival, proliferation, and migration<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>. Furthermore, Bufalin has been shown to downregulate the expression of transcriptional coactivators SRC-1 and SRC-3, as well as the nuclear transcription factor E2F1<sup><a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>,<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a></sup>. Bufalin induced apoptosis, necroptosis, ferroptosis, autophagy, and senescence through AMPK, RIP1/ROS, DECR1, p62, and p53 pathways<sup><a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>,<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>â€“<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a></sup>. Recent studies indicated that Bufalin played an important role in the tumor microenvironment by inducing the activation of the NF-ÎºB pathway<sup><a href="#CR2" class="usa-link" aria-describedby="CR2">2</a></sup>. Bufalin also appears to regulate particular non-coding RNAs, including microRNA-203 (miR-203), to suppress tumor cell proliferation<sup><a href="#CR49" class="usa-link" aria-describedby="CR49">49</a></sup>. Here, we found that Bufalin may serve as a molecular glue that strengthens the ERÎ±-STUB1 interaction, thereby driving the degradation of ERÎ±. Previous studies have reported that Bufalin exerts anti-tumor effects by inhibiting SRC in MCF-7 cells<sup><a href="#CR8" class="usa-link" aria-describedby="CR8">8</a></sup>. However, compared to SRC, the ERÎ± constitutes the central oncogenic driver in ER+ breast cancer, as ERÎ± overexpression promotes tumorigenesis<sup><a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>,<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a></sup>. Targeting ERÎ± signaling is widely regarded as the most effective therapeutic strategy for ERÎ±-positive breast cancer, such as Tamoxifen, Fulvestrant, and Letrozole, which have brought significant prognostic improvements for ER+ breast cancer<sup><a href="#CR52" class="usa-link" aria-describedby="CR52">52</a></sup>. Our research uncovers a promising ERÎ±-targeting therapeutic strategy by demonstrating that Bufalin can selectively induce the degradation of ERÎ±.</p>
<p id="Par24">Our results demonstrate Bufalin-induced ERÎ± degradation drives its anticancer activity, suggesting selective cytotoxicity in ERÎ±-expressing malignancies, including cervical and colorectal cancers. Structural analysis revealed that Bufalin could selectively bind to the R394 of the ERÎ± protein and effectively inhibited the estrogen response elements transcriptional activity. These findings, on one hand, clarified the anti-tumor target of Bufalin with defined binding residues for molecular optimization, on the other hand, provided an experimental basis for expanding the range of possible future applications of Bufalin.</p>
<p id="Par25">Targeted protein degradation (TPD), including molecular glues and PROTACs, has emerged as a promising strategy to target proteins previously considered undruggable<sup><a href="#CR53" class="usa-link" aria-describedby="CR53">53</a></sup>. Unlike conventional inhibitors, molecular glues facilitate protein degradation by inducing proximity between the target and E3 ligases and have gained attention as a potential strategy for targeting proteins<sup><a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>,<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a></sup>. Numerous small molecules have entered the clinical research stage. Previous research has revealed that Bufalin as a molecular glue that targets E2F2 and inhibits the growth of hepatoma<sup><a href="#CR56" class="usa-link" aria-describedby="CR56">56</a></sup>. Here, we demonstrate that Bufalin enhances ERÎ±â€™s association with the ubiquitin E3 ligase STUB1 by acting as a molecular glue, which results in proteasome-mediated degradation of ERÎ±. Our study expands insights into molecular glues and provides a structural foundation for the development of structure-guided Bufalin derivatives.</p>
<p id="Par26">Although Tamoxifen remains the standard first-line treatment for ER-positive breast cancer and has significantly improved patient prognosis, the development of acquired resistance continues to pose a major clinical challenge<sup><a href="#CR57" class="usa-link" aria-describedby="CR57">57</a></sup>. Therefore, how to improve the therapeutic effect of Tamoxifen and reverse resistance has been extensively investigated. An increasing number of endocrine-resistance mechanisms have been characterized, and several small molecules have been reported to overcome Tamoxifen resistance<sup><a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>,<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a></sup>. Our previous study has reported that the UCH-L1 inhibitor LDN significantly enhanced the efficacy of Tamoxifen both in vivo and in vitro<sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup>. Fulvestrant is a standard therapeutic option for endocrine-resistant or advanced metastatic ER+ breast cancer<sup><a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>,<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a></sup>. In line with this, recent studies have shown that ERÎ±-targeting PROTACs can also effectively degrade ERÎ± and combat endocrine-resistant breast cancer<sup><a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>,<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a></sup>. In our study, we observed high ERÎ± expression in samples from patients with endocrine treatment relapse, aligning with previous findings. Moreover, as a molecular glue of ERÎ±, Bufalin exhibited potent anti-cancer effects in vitro, in vivo, and in Tamoxifen-resistant patient-derived organoids. By degrading ERÎ±, Bufalin has the potential to reverse Tamoxifen resistance, offering a promising therapeutic strategy for patients with limited treatment options.</p>
<p id="Par27">In summary, our study demonstrates that Bufalin selectively binds to the R394 residue of ERÎ± and promotes its degradation based on the AI-driven methods. Additionally, Bufalin functions as a molecular glue, facilitating the interaction between ERÎ± and the ubiquitin E3 ligase STUB1, ultimately leading to proteasomal degradation of ERÎ±. Furthermore, Bufalin exhibits potent anti-cancer activity against Tamoxifen-resistant breast cancer in both preclinical models and patient-derived organoids. Collectively, our findings not only establish Bufalin as a molecular glue for ERÎ± degradation but also highlight its potential as a promising lead compound for the treatment of Tamoxifen resistance.</p></section><section id="Sec12"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec13"><h3 class="pmc_sec_title">Ethics approval</h3>
<p id="Par28">The experiments were approved by the Medical Ethics Review Committee of Xiangya Hospital of Central South University (Ethics code: 2023121169). Tissue samples were collected from the Xiangya Hospital of Central South University (Changsha, China), and all individuals provided informed consent prior to participating in the study.</p>
<p id="Par29">Animal studies were approved by the Institutional Animal Care and Use Committee (IACUC) of Central South University (CSU-2023-0462), and all procedures were conducted in accordance with the institutional guidelines of the Animal Care and Use Committee of Central South University. All mice were housed in the Laboratory Animal Research Center of Central South University, which is a pathogen-free animal facility at a controlled temperature under standard laboratory conditions (12â€‰h light/dark cycle, temperature kept at 21â€“24â€‰Â°C and 40â€“70% humidity) with food and water provided ad libitum. Female mice were selected because the study focuses on breast cancer, a disease that predominantly affects females and is influenced by female-specific hormonal and physiological factors. In compliance with ethical regulations, tumor volume did not exceed 2000 mmÂ³, and no single tumor dimension exceeded 20â€‰mm in diameter.</p></section><section id="Sec14"><h3 class="pmc_sec_title">Target prediction of Bufalin based on an integrated multi-predictive strategy</h3>
<p id="Par30">To refine the target prediction range, we trained a deep learning model based on the Chemprop<sup><a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup> package using binding data from 11 targets sourced from ChEMBL and PubChem, with an average of 1187 compounds per target (Supplementary TableÂ <a href="#MOESM1" class="usa-link">2</a>). The dataset was randomly split into an 80% training set and a 20% test set.</p>
<p id="Par31">The model employs a Graph Neural Network (GNN) architecture specifically designed to learn molecular representations from graph-structured data. It consists of four primary components: (1) a shared local feature encoder that extracts atom and bond features across all tasks; (2) a directed message-passing process that propagates information along directed edges to generate atom embeddings; (3) an aggregation module that combines atom embeddings into a single molecular representation using sum or mean pooling; and (4) a feed-forward network (FFN) with task-specific multi-layer perceptron (MLP) layers to map molecular embeddings to target properties, enabling efficient multi-task predictions.</p>
<p id="Par32">The model was trained with the Adam optimizer, incorporating learning rate scheduling, dropout regularization, and a model-ensembling strategy. Together with an advanced GNN architecture and a carefully curated dataset, this results in a robust and high-performing model, achieving a receiver operating characteristic area under the curve (ROC-AUC) of 0.94 on the test set (Supplementary TableÂ <a href="#MOESM1" class="usa-link">3</a>). Finally, a default probability threshold of 0.8 was applied, ensuring that only targets meeting this performance criterion were selected.</p></section><section id="Sec15"><h3 class="pmc_sec_title">Cell lines and culture</h3>
<p id="Par33">All cell lines were maintained at 37 Â°C in a humidified atmosphere of 5% CO<sub>2</sub>/95% air. MCF-7 cells were purchased from Cell Bank (Chinese Academy of Sciences, Beijing, China). The T47D and 293â€‰T cell lines were purchased from Cell Bank (Chinese Academy of Sciences, Shanghai, China). The Tamoxifen-resistant cells LCC2 were derived from Wuhan University. MCF-7 and 293â€‰T cells were cultured in Dulbeccoâ€™s Modified Eagle Medium (DMEM) (Gibco, Carlsbad, CA, USA) with 10% Fetal Bovine Serum and 1% penicillin streptomycin. T47D were cultured in RPMI-1640 medium (Gibco, Carlsbad, CA, USA) with 10% Fetal Bovine Serum and 1% penicillin streptomycin. Tamoxifen-resistant LCC2 cells were cultured according to the literature<sup><a href="#CR52" class="usa-link" aria-describedby="CR52">52</a></sup>, briefly, LCC-2 cell lines were cultured in RPMI-1640 medium (10% Fetal Bovine Serum and 1% penicillin streptomycin). All cell lines were tested negative for mycoplasma contamination.</p></section><section id="Sec16"><h3 class="pmc_sec_title">Reagents and Antibodies</h3>
<p id="Par34">Bufalin was purchased from APExBIO (USA). Fulvestrant, Estradiol (E2), and MG-132 were purchased from MedChemExpress (Monmouth Junction, NJ, USA). MLN4924 was purchased from TargetMol (Washington, USA). The recombinant Human CYP17A1 (cat. no. CSB-EP006392HU) and estrogen receptor (ESR1) (Cat. no. CSB-YP007830HU) proteins were purchased from <a href="https://www.cusabio.com/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CUSABIO</a>. Recombinant human PKC delta protein (ab60844) was purchased from Abcam (Cambridge, UK). Antibodies targeting ERÎ± (Cat. no. 8644, WB, 1:1000), LC3 (Cat. no. 12741, WB,1:1000), PARP (Cat. no. 9532, WB,1:1000), and Bcl-2 (Cat. no.15071, WB, 1:1000) were purchased from Cell Signaling Technology (Danvers, MA, USA). The ERÎ± (cat. no. 84564-4-RR, IHC, 1:500, IF, 1:250), STUB1 (Cat. no. 68407-1-Ig, WB, 1:1000), and Î²-actin (Cat. no. 81115-1-RR, WB, 1:5000) antibodies were purchased from Proteintech (Chicago, IL, USA). The Flag (cat. no. M185, WB, 1:1000) and HA antibodies (cat. no. M180, WB, 1:1000) were purchased from MBL (Tokyo, Japan), while the antibody against ubiquitin (cat. no. sc-8017, WB, 1:200) was purchased from Santa Cruz Biotechnology. Anti-mouse and anti-rabbit secondary antibodies were purchased from Abiowell (Shanghai, China). Streptavidin FITC (Cat. no. 11-4317-87) was purchased from Thermo Fisher Scientific (Waltham, MA, USA). Magnetic streptavidin beads (cat. no. 22305-1) were purchased from Beaver (Suzhou, China). Lipofectamine 8000 was purchased from Beyotime Biotechnology (Shanghai, China). Lipofectamineâ„¢ RNAiMAX was purchased from Invitrogen. Protein A/G agarose beads (cat. no. 10121) were obtained from Santa Cruz Biotechnology, and the CCK-8 was purchased from Bimake (Shanghai, China). An enhanced chemiluminescence kit (cat. no. BL520A) was purchased from BioSharp (Shanghai, China).</p></section><section id="Sec17"><h3 class="pmc_sec_title">Plasmid and siRNA transfection</h3>
<p id="Par35">Plasmids encoding wild-type and mutant ERÎ± were obtained from Gene (Shanghai, China), while siRNAs targeting ESR1 and STUB1 were purchased from GenePharma (Suzhou, China). The target sequence of ESR1 siRNA was as follows: GCACCCUCUUGUAUUCCUATT (sense), UAGGAAUACAAGAGGGUGCTT (antisense). The target sequence of STUB1 siRNA was as follows: GCAGUCUGUGAAGGCGCACTT (sense), GUGCGCCUUCACAGACUGCTT (antisense). For siRNA transfection, the siRNA targeting ESR1 or STUB1 was incubated with Lipofectamineâ„¢ RNAiMAX in serum-free medium according to the manufacturerâ€™s instructions. The plasmid was transfected using the Lipofectamine 8000 reagent in serum-free DMEM, according to the manufacturerâ€™s instructions.</p></section><section id="Sec18"><h3 class="pmc_sec_title">Western Blot</h3>
<p id="Par36">After treatment, the cells were washed twice with cold PBS and lysed on ice for 30â€‰minutes in RIPA lysis (â€ŒAbiowell) supplemented with a protease inhibitor cocktail (Biotool), followed by centrifugation at 12,000â€‰<em>g</em> for 15â€‰minutes at 4â€‰Â°C. The protein concentration of the supernatant was determined using BCA. Proteins were resolved by SDS-PAGE and then transferred to PVDF membrane (Merck KGaA, Darmstadt, Germany). The PVDF membranes were blocked with 5% skim milk for 1â€‰h at room temperature and then incubated with the respective antibodies at 4â€‰Â°C for 14â€‰h. After 14â€‰h the PVDF membranes were washed thrice with PBST and incubated with a secondary antibody at room temperature for 1â€‰h. The signals were detected by chemiluminescence assay using a ChemiDoc Touch (Bio-Rad).</p></section><section id="Sec19"><h3 class="pmc_sec_title">Cell viability assays</h3>
<p id="Par37">Briefly, cells were seeded into 96-well plates at an appropriate density and allowed to adhere overnight. The following day, cells were treated with various concentrations of the indicated drug and incubated for the desired time period. Subsequently, 10â€‰Î¼L of CCK-8 solution was added to each well and the plates were incubated at 37â€‰Â°C for 1-2â€‰hours. After incubation, absorbance was measured at 450â€‰nm using a microplate reader.</p></section><section id="Sec20"><h3 class="pmc_sec_title">Colony forming assay</h3>
<p id="Par38">MCF-7, T47D, and LCC2 cells were seeded in 6-well plates, exposed to the indicated treatments, and cultured for approximately 15 days, and the medium was changed every 3 days. After treatment, the cells were fixed with 4% paraformaldehyde, stained with crystal violet for 24â€‰h, washed with water, and colonies were counted.</p></section><section id="Sec21"><h3 class="pmc_sec_title">5-Ethynyl-2â€™- deoxyuridine Assay (EdU)</h3>
<p id="Par39">After treatment with Bufalin, LCC2 cells were incubated with 5-ethynyl-2â€²-deoxyuridine (EdU; RiboBio, Guangzhou, China) for 2â€‰hours at 37â€‰Â°C, according to the manufacturerâ€™s instructions. The cells were fixed with 4% paraformaldehyde at room temperature for 30â€‰min, followed by treatment with 2â€‰mg/mL glycine for 5â€‰min. Next, the cells were permeabilized with 0.5% Triton X-100 for 10â€‰min and stained with a 1Ã— Apollo reaction cocktail for 30â€‰min in the dark at room temperature. Finally, cell nuclei were counterstained with Hoechst 33342 for 30â€‰min at room temperature. Images were captured using a fluorescence microscope.</p></section><section id="Sec22"><h3 class="pmc_sec_title">Quantitative Real-time PCR</h3>
<p id="Par40">Total RNA was isolated from cells using the TRIzol reagent (CWBio, Taizhou, China), and reverse transcription was carried out using the PrimeScript RT reagent kit (TaKaRa, Japan) to generate complementary DNA (cDNA). Quantitative real-time PCR was conducted on a QuantStudio Real-Time PCR System (Life Technologies) using QuantStudio Design &amp; Analysis Software v1.5.1. Gene expression levels were quantified using the standard 2<sup>âˆ’Î”Î”Ct</sup> method. The qPCR primer sets were: ESR1: GGGAAGTATGGCTATGGAATCTG (forward), TGGCTGGACACATATAGTCGTT (reverse); AGR2: AGAGCAGTTTGTCCTCCTCAA (forward), CAGGTTCGTAAGCATAGAGACG (reverse); CCND1: CAATGACCCCGCACGATTTC (forward), CATGGAGGGCGGATTGGAA (reverse); GREB1: TGGTCCGTAATGCACAAGGG (forward), CTGCGTTTAGTGAGGGGTGA (reverse); NRIP1: GGATCAGGTACTGCCGTTGAC (forward), CTGGACCATTACTTTGACAGGTG (reverse); PGR: TTATGGTGTCCTTACCTGTGGG (forward), GCGGATTTTATCAACGATGCAG (reverse); SIAH2: TCTTCGAGTGTCCGGTCTG (forward), CGGCATTGGTTACACACCAG (reverse), GAPDH: TGACATCAAGAAGGTGGTGAAGCAG (forward), GTGTCGCTGTTGAAGTCAGAGGAG (reverse).</p></section><section id="Sec23"><h3 class="pmc_sec_title">Flow-cytometric analysis of apoptosis</h3>
<p id="Par41">After Bufalin treatment, the cells were collected and washed twice with cold PBS. Subsequently, 5â€‰Î¼L Annexin V-FITC and 5â€‰Î¼L propidium iodide (PI) staining buffer were added to the cells and incubated in the dark at room temperature. After 15â€‰min, the stained cells were analyzed using FACS.</p></section><section id="Sec24"><h3 class="pmc_sec_title">Immunofluorescence staining</h3>
<p id="Par42">MCF-7 cells treated with Biotin-Bufalin on glass coverslips were fixed in 4% paraformaldehyde for 30â€‰min at room temperature and blocked with 5% bovine serum albumin (BSA) for 1â€‰h. The fixed cells were then incubated with anti-ERÎ± antibody and streptavidin FITC at 4â€‰Â°C overnight, followed by Alexa Fluor 594 anti-rabbit IgG antibody. At the end of the incubation period, the cells' nuclei were stained with DAPI, and the fluorescence signal was detected and captured using confocal microscopy.</p></section><section id="Sec25"><h3 class="pmc_sec_title">Co-immunoprecipitation (Co-IP) assay</h3>
<p id="Par43">The 293â€‰T cells were transiently transfected with Flag-ERÎ± plasmid or HA-STUB1 and subjected to Bufalin treatment as indicated. After treatment, the cells were washed twice with PBS and lysed in mammalian protein extraction reagent buffer (cat. no. 78501; Thermo Scientific), supplemented with protease and phosphatase inhibitors for 30â€‰min. Cell lysates were centrifuged, and supernatant was precleared with protein G agarose beads (Santa Cruz), then subjected to immunoprecipitation with indicated antibodies and protein A/G agarose beads at 4â€‰Â°C overnight. The next day, the immunocomplexes were washed five times with PBS, and the binding proteins were eluted by 1 Ã— SDS-PAGE loading buffer at 95â€‰Â°C for 10â€‰min. Bound proteins were identified using immunoblotting and western blot.</p></section><section id="Sec26"><h3 class="pmc_sec_title">Biotin-pull down assay</h3>
<p id="Par44">After treatment, the cells were washed with PBS and lysed for 30â€‰min in mammalian protein extraction (Thermo Scientific) with protease and phosphatase inhibitors. Following cell lysis, the supernatants were collected by centrifugation at 12,000 Ã— <em>g</em> for 15â€‰minutes at 4â€‰Â°C. The streptavidin magnetic beads were pre-incubated with the cell lysate for 2â€‰hours. Subsequently, 500â€‰Î¼g of clarified cell lysate was incubated with either D-Biotin or Biotin-Bufalin overnight at 4â€‰Â°C for target protein capture. The following day, the mixture containing biotin and cell lysate was coupled with streptavidin magnetic beads (Beaver) for 2â€‰hours at room temperature. The magnetic beads were then collected using a magnetic rack and washed six times to remove non-specifically bound proteins. Bound proteins were eluted by boiling in 1Ã— SDS-PAGE loading buffer at 95â€‰Â°C for 10â€‰minutes, followed by detection via western blot analysis.</p></section><section id="Sec27"><h3 class="pmc_sec_title">Animal studies</h3>
<p id="Par45">Briefly, the Tamoxifen-resistant cells LCC2 (2 Ã— 10<sup>6</sup> cells) were subcutaneously injected into 4-week-old female nude mice (Hunan Slack Jingda Laboratory Animal Co., Ltd.). Tumor sizes were measured on different days after inoculation and calculated using the formula V = lw<sup>2</sup>Ï€/6, where l is the length and w is the width. When the tumors were palpable, the mice were randomly divided into designated groups and received the indicated treatments. The tumor volume was measured using a Vernier caliper every two days.</p></section><section id="Sec28"><h3 class="pmc_sec_title">Immunohistochemistry (IHC)</h3>
<p id="Par46">The human cancer tissue specimens from patients with Tamoxifen treatment and recurrence, and animal tissue were fixed in 4% paraformaldehyde, embedded in paraffin, and sectioned at a thickness of 4 Î¼m. After deparaffinization, antigen retrieval was performed using a citric acid buffer (pH 6.0). Endogenous peroxidase activity was blocked with 3% hydrogen peroxide, and following blocked with the application of normal serum. Sections were then incubated overnight at 4â€‰Â°C with the antibodies against ERÎ± and Ki67, followed by HRP-conjugated secondary antibodies. The signal was developed using DAB, and the nuclei were counterstained with hematoxylin. Immunohistochemical staining was performed according to the manufacturerâ€™s protocol.</p></section><section id="Sec29"><h3 class="pmc_sec_title">Protein-ligand binding conformation modeling</h3>
<p id="Par47">The conformation of the protein-ligand complex was modeled using SchrÃ¶dinger software (version 2022.1). The structure of Bufalin was obtained from PubChem, and ligand conformations were generated using LigPrep. The crystal structure of the ESR1 protein was obtained from the Protein Data Bank (PDB ID: 3ERT)<sup><a href="#CR63" class="usa-link" aria-describedby="CR63">63</a></sup>. The Glide SP protocol was employed to generate the optimal conformation of the protein-ligand complex.</p></section><section id="Sec30"><h3 class="pmc_sec_title">Protein-protein docking conformation modeling</h3>
<p id="Par48">The structures of STUB1, TRIM56, RNF181, RNF2, and ESR1 proteins were obtained from the Protein Data Bank and Alphafold 3, and subjected to 15 repeats of optimization using the relax module of Rosetta (version 3.5.1)<sup><a href="#CR64" class="usa-link" aria-describedby="CR64">64</a></sup>. Ten conformations were generated from each optimization, and the top-scoring conformation from Rosetta was used for subsequent protein-protein docking. Initial protein-protein docking was performed using the ClusPro server<sup><a href="#CR65" class="usa-link" aria-describedby="CR65">65</a></sup>. Complex conformations with incorrect STUB1, TRIM56, RNF181, and RNF2 binding modes were excluded from the ClusPro docking results. These conformations were subjected to structural refinement using the docking protocol of Rosetta. All generated conformations were ranked according to their Rosetta scores.</p></section><section id="Sec31"><h3 class="pmc_sec_title">Molecular dynamic simulations</h3>
<p id="Par49">Molecular simulations of ESR1-Bufalin, ESR1-STUB1, and ESR1-Bufalin-STUB1 complexes were conducted using Amber22 software. Proteins and ligands were parameterized using Amber ff19SB<sup><a href="#CR66" class="usa-link" aria-describedby="CR66">66</a></sup> and GAFF2<sup><a href="#CR67" class="usa-link" aria-describedby="CR67">67</a></sup> force fields, respectively. The complex systems were solvated in a TIP3P water box extending 10â€‰Ã… from the protein. Chloride and sodium ions were then added to neutralize the system. Subsequently, energy minimization was performed for up to 20,000 steps. The systems were heated from 0â€‰K to 298.15â€‰K over 100â€‰ps and the pressure was increased to atmospheric pressure over another 100â€‰ps, with a time step of 1â€‰fs during the heating and pressurization processes. Finally, a 200â€‰ns production classical MD simulation was conducted with a time step of 2â€‰fs. Trajectory analysis was performed using CPPTRAJ.</p></section><section id="Sec32"><h3 class="pmc_sec_title">MM-PBSA and alanine scanning mutations analysis</h3>
<p id="Par50">MM-PBSA binding free energy calculations were performed using MMPBSA.py from AmberTools2023<sup><a href="#CR68" class="usa-link" aria-describedby="CR68">68</a></sup>, using only the last 100â€‰ns of the trajectory. We extracted 100 frames from the trajectory for subsequent energy calculations. In addition, residual energy decomposition was performed for the Bufalin-ESR1 complex. Alanine scanning mutations<sup><a href="#CR69" class="usa-link" aria-describedby="CR69">69</a></sup> were conducted on the top ten residues from the energy decomposition analysis.</p></section><section id="Sec33"><h3 class="pmc_sec_title">Surface Plasmon Resonance (SPR) assay</h3>
<p id="Par51">After storage at -80â€‰Â°C, Bufalin and the recombinant proteins CYP17A1, ESR1, and PKC delta were allowed to equilibrate to room temperature. Bufalin was diluted with DMSO to the appropriate concentration for spotting and used as the immobilized phase. The working solution was printed onto a 3D photocrosslinkable sensor chip using the BioDotâ„¢ AD1520 microarray printer, with four nonadjacent replicate spots per compound. The printed chips were vacuum-dried and then subjected to UV-induced photocrosslinking using a crosslinking instrument. Following crosslinking, the chips were sequentially washed on a shaker with DMF, ethanol (EtOH), and deionized water for 15â€‰minutes each. The recombinant protein samples were diluted to generate five concentration gradients: 200â€‰nM, 400â€‰nM, 800â€‰nM, 1600â€‰nM, and 3200â€‰nM, and were injected over the chip surface. During interaction analysis, the protein analytes were passed over the chip surface at a flow rate of 0.5â€‰Î¼L/s. Each association phase lasted 600â€‰seconds, followed by a 360-second dissociation phase. After each binding cycle, the chip surface was regenerated with 10â€‰mM glycine-HCl (pHâ€‰2.0) at a flow rate of 2â€‰Î¼L/s to remove the bound analytes.</p></section><section id="Sec34"><h3 class="pmc_sec_title">Patient-derived organoid</h3>
<p id="Par52">Tissue specimens from patients who relapsed after Tamoxifen therapy were processed for organoid culture according to previous protocols<sup><a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>,<a href="#CR71" class="usa-link" aria-describedby="CR71">71</a></sup>. Samples were obtained from the Xiangya Hospital of Central South University (Changsha, China), and written informed consent was obtained from all participants prior to collection. Tissue samples were enzymatically digested into single-cell suspensions using collagenase (Sigma) and subsequently cultured in a 3D environment composed of 50% chilled Matrigel (Corning). After 5 days of culture, the resulting organoids were dissociated into single-cell suspensions, seeded into 384-well plates, and treated with Bufalin. After 4 days of treatment, cell viability was assessed using CellTiter-Glo 3D Reagent (Promega) according to the manufacturerâ€™s instructions.</p></section><section id="Sec35"><h3 class="pmc_sec_title">Organoid live/dead cell staining</h3>
<p id="Par53">Live/dead organoid cell staining was performed as previously described<sup><a href="#CR72" class="usa-link" aria-describedby="CR72">72</a></sup>. Following treatment, the samples were washed twice with cold PBS and subsequently stained with Calcein-AM and propidium iodide (PI) at 37â€‰Â°C for 20â€‰minutes in the dark. Finally, the images were captured using a fluorescence microscope.</p></section><section id="Sec36"><h3 class="pmc_sec_title">Statistics and reproducibility</h3>
<p id="Par54">We analyzed the data using GraphPad Prism 9.0 software. All samples represent biological replicates, and the statistical measurements are presented as meanâ€‰Â±â€‰SD as specified in each figure. No statistical method was used to predetermine sample size. No data were excluded from the analyses. The experiments were randomized. The Investigators were blinded to allocation during experiments and outcome assessment. Statistical analyses were performed using one-way or two-way ANOVA, depending on the experimental design. A <em>P</em>-valueâ€‰&lt;â€‰0.05 was considered statistically significant. The <em>P</em> values are given in the figures. All representative experiments are repeated at least three times independently with similar results.</p></section><section id="Sec37"><h3 class="pmc_sec_title">Reporting summary</h3>
<p id="Par55">Further information on research design is available in theÂ <a href="#MOESM2" class="usa-link">Nature Portfolio Reporting Summary</a> linked to this article.</p></section></section><section id="Sec38"><h2 class="pmc_sec_title">Supplementary information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12373995/bin/41467_2025_62288_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Information</a><sup> (305.2KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12373995/bin/41467_2025_62288_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Reporting Summary</a><sup> (3.5MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM3"><div class="media p"><div class="caption">
<a href="/articles/instance/12373995/bin/41467_2025_62288_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Transparent Peer Review file</a><sup> (446.6KB, pdf) </sup>
</div></div></section></section><section id="Sec39"><h2 class="pmc_sec_title">Source data</h2>
<section class="sm xbox font-sm" id="MOESM4"><div class="media p"><div class="caption">
<a href="/articles/instance/12373995/bin/41467_2025_62288_MOESM4_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Source Data</a><sup> (3.1MB, xlsx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We gratefully acknowledge Professor Ceshi Chen (Kunming Medical University) for generously providing the HA-STUB1 plasmid, and Professor Haibing Zhou (Wuhan University) for the kind gift of the Tamoxifen-resistant LCC2 cell line. This work was supported by National Key Research and Development Program of China (2021YFF1201400 to DS C), the National Natural Science Foundation of China (22173118 to DS C, 82304553 to SL J), the Science and Technology Innovation Program of Hunan Province (2021RC4011 to DS C), Hunan Provincial Leading Talents in Scientific and Technological Innovation (Top Tier) Program (2022RC3076 to Y C), the Natural Science Foundation of Hunan Province (2022JJ80104 to DS C, 2023JJ40952 to SL J), the Natural Science Foundation of Changsha Municipal (kq2208407 to SL J), Talent Project Established by Chinese Pharmaceutical Association Hospital Pharmacy Department (CPA-Z05-ZC-2023-003 to SL J). We acknowledge Haikun Xu, Ph.D, and the High-Performance Computing Center of Central South University for support.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Y.C. and D.S.C. designed the study and revised the manuscript. S.L.J., T.J., X.W., X.Y.W., R.G., and C.X.Z. performed the experiments and analyzed the experimental data. H.L. conducted molecular docking experiments. S.L.J., K.Y.L., and T.J. drafted the manuscript. Z.L.C., C.Z., and Q.Z. helped with data analysis.</p></section><section id="notes2"><h2 class="pmc_sec_title">Peer review</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Peer review information</h3>
<p id="Par56"><em>Nature Communications</em> thanks Tao Zhu, Shirley Siu, Hui Yu, and the other anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.</p></section></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>All data are included within the article, supplementary information or source data file.Â <a href="#Sec39" class="usa-link">Source data</a> are provided with this paper.</p></section><section id="notes4"><h2 class="pmc_sec_title">Code availability</h2>
<p>The code has been made available on GitHub (<a href="https://github.com/wei-xiao-ya/multi_task-NN" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/wei-xiao-ya/multi_task-NN</a>, <a href="https://github.com/LiHui-CADD/pro1-pro2-lig/tree/master" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/LiHui-CADD/pro1-pro2-lig/tree/master</a>). The molecular docking and MD simulation data are available in the â€œInputFileâ€ and â€œcodeâ€ sections, respectively, at <a href="https://github.com/LiHui-CADD/pro1-pro2-lig/tree/master" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/LiHui-CADD/pro1-pro2-lig/tree/master</a>.</p></section><section id="FPar2"><h2 class="pmc_sec_title">Competing interests</h2>
<p id="Par57">The authors declare no competing interests.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1"><p><strong>Publisherâ€™s note</strong> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div>
<div class="fn p" id="fn2"><p>These authors contributed equally: Shilong Jiang, Keyi Liu, Ting Jiang.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Yan Cheng, Email: yancheng@csu.edu.cn.</p>
<p>Dongsheng Cao, Email: oriental-cds@163.com.</p></section><section id="sec40"><h2 class="pmc_sec_title">Supplementary information</h2>
<p>The online version contains supplementary material available at 10.1038/s41467-025-62288-7.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Zhang, H. et al. Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/Î²-catenin signal pathway. <em>J. Transl. Med.</em><strong>21</strong>, 900 (2023).
</cite> [<a href="https://doi.org/10.1186/s12967-023-04613-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10714474/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38082327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang,%20H.%20et%20al.%20Bufalin%20targeting%20CAMKK2%20inhibits%20the%20occurrence%20and%20development%20of%20intrahepatic%20cholangiocarcinoma%20through%20Wnt/%CE%B2-catenin%20signal%20pathway.%20J.%20Transl.%20Med.21,%20900%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Yu, Z. et al. Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma. <em>J. Immunother. Cancer</em><strong>10</strong>, e004297 (2022).
</cite> [<a href="https://doi.org/10.1136/jitc-2021-004297" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9125767/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35618286/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yu,%20Z.%20et%20al.%20Bufalin%20stimulates%20antitumor%20immune%20response%20by%20driving%20tumor-infiltrating%20macrophage%20toward%20M1%20phenotype%20in%20hepatocellular%20carcinoma.%20J.%20Immunother.%20Cancer10,%20e004297%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Farooqi, A. A. et al. Bufalin-mediated regulation of cell signaling pathways in different cancers: spotlight on JAK/STAT, Wnt/Î²-Catenin, mTOR, TRAIL/TRAIL-R, and non-coding RNAs. <em>Molecules</em><strong>28</strong>, 2231 (2023).
</cite> [<a href="https://doi.org/10.3390/molecules28052231" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10004807/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36903477/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Farooqi,%20A.%20A.%20et%20al.%20Bufalin-mediated%20regulation%20of%20cell%20signaling%20pathways%20in%20different%20cancers:%20spotlight%20on%20JAK/STAT,%20Wnt/%CE%B2-Catenin,%20mTOR,%20TRAIL/TRAIL-R,%20and%20non-coding%20RNAs.%20Molecules28,%202231%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Chen, J. et al. Bufalin targets the SRC-3/MIF pathway in chemoresistant cells to regulate M2 macrophage polarization in colorectal cancer. <em>Cancer Lett.</em><strong>513</strong>, 63â€“74 (2021).
</cite> [<a href="https://doi.org/10.1016/j.canlet.2021.05.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34000344/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen,%20J.%20et%20al.%20Bufalin%20targets%20the%20SRC-3/MIF%20pathway%20in%20chemoresistant%20cells%20to%20regulate%20M2%20macrophage%20polarization%20in%20colorectal%20cancer.%20Cancer%20Lett.513,%2063%E2%80%9374%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Soumoy, L., Ghanem, G. E., Saussez, S. &amp; Journe, F. Bufalin for an innovative therapeutic approach against cancer. <em>Pharm. Res.</em><strong>184</strong>, 106442 (2022).</cite> [<a href="https://doi.org/10.1016/j.phrs.2022.106442" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36096424/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Soumoy,%20L.,%20Ghanem,%20G.%20E.,%20Saussez,%20S.%20&amp;%20Journe,%20F.%20Bufalin%20for%20an%20innovative%20therapeutic%20approach%20against%20cancer.%20Pharm.%20Res.184,%20106442%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Qian, Z. et al. Bufalin inhibits the proliferation of lung cancer cells by suppressing Hippo-YAP pathway. <em>Cell Signal</em><strong>109</strong>, 110746 (2023).
</cite> [<a href="https://doi.org/10.1016/j.cellsig.2023.110746" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37286119/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qian,%20Z.%20et%20al.%20Bufalin%20inhibits%20the%20proliferation%20of%20lung%20cancer%20cells%20by%20suppressing%20Hippo-YAP%20pathway.%20Cell%20Signal109,%20110746%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Chen, G. et al. Bufalin targeting BFAR inhibits the occurrence and metastasis of gastric cancer through PI3K/AKT/mTOR signal pathway. <em>Apoptosis</em><strong>28</strong>, 1390â€“1405 (2023).
</cite> [<a href="https://doi.org/10.1007/s10495-023-01855-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37253905/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen,%20G.%20et%20al.%20Bufalin%20targeting%20BFAR%20inhibits%20the%20occurrence%20and%20metastasis%20of%20gastric%20cancer%20through%20PI3K/AKT/mTOR%20signal%20pathway.%20Apoptosis28,%201390%E2%80%931405%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Wang, Y. et al. Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1. <em>Cancer Res.</em><strong>74</strong>, 1506â€“1517 (2014).
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-13-2939" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3947477/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24390736/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang,%20Y.%20et%20al.%20Bufalin%20is%20a%20potent%20small-molecule%20inhibitor%20of%20the%20steroid%20receptor%20coactivators%20SRC-3%20and%20SRC-1.%20Cancer%20Res.74,%201506%E2%80%931517%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Qiu, Y. &amp; Cheng, F. Artificial intelligence for drug discovery and development in Alzheimerâ€™s disease. <em>Curr. Opin. Struct. Biol.</em><strong>85</strong>, 102776 (2024).
</cite> [<a href="https://doi.org/10.1016/j.sbi.2024.102776" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38335558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qiu,%20Y.%20&amp;%20Cheng,%20F.%20Artificial%20intelligence%20for%20drug%20discovery%20and%20development%20in%20Alzheimer%E2%80%99s%20disease.%20Curr.%20Opin.%20Struct.%20Biol.85,%20102776%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Pun, F. W., Ozerov, I. V. &amp; Zhavoronkov, A. AI-powered therapeutic target discovery. <em>Trends Pharm. Sci.</em><strong>44</strong>, 561â€“572 (2023).
</cite> [<a href="https://doi.org/10.1016/j.tips.2023.06.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37479540/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pun,%20F.%20W.,%20Ozerov,%20I.%20V.%20&amp;%20Zhavoronkov,%20A.%20AI-powered%20therapeutic%20target%20discovery.%20Trends%20Pharm.%20Sci.44,%20561%E2%80%93572%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Wei, H. et al. A combinatorial target screening strategy for deorphaning macromolecular targets of natural product. <em>Eur. J. Med. Chem.</em><strong>204</strong>, 112644 (2020).
</cite> [<a href="https://doi.org/10.1016/j.ejmech.2020.112644" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32738412/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wei,%20H.%20et%20al.%20A%20combinatorial%20target%20screening%20strategy%20for%20deorphaning%20macromolecular%20targets%20of%20natural%20product.%20Eur.%20J.%20Med.%20Chem.204,%20112644%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Cao, D. S. et al. A multi-scale systems pharmacology approach uncovers the anti-cancer molecular mechanism of Ixabepilone. <em>Eur. J. Med. Chem.</em><strong>199</strong>, 112421 (2020).
</cite> [<a href="https://doi.org/10.1016/j.ejmech.2020.112421" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32428794/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cao,%20D.%20S.%20et%20al.%20A%20multi-scale%20systems%20pharmacology%20approach%20uncovers%20the%20anti-cancer%20molecular%20mechanism%20of%20Ixabepilone.%20Eur.%20J.%20Med.%20Chem.199,%20112421%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Wei, X. et al. Predicting novel targets with Bayesian machine learning by integrating multiple biological signatures. <em>Chem. Sci.</em><strong>15</strong>, 14471â€“14484 (2024).</cite> [<a href="https://doi.org/10.1039/d4sc03580a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11333953/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39170720/" class="usa-link">PubMed</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Deng, X. et al. Identification of Novel Dual-Target Estrogen Receptor Î± Degraders with Tubulin inhibitory activity for the treatment of endocrine-resistant breast cancer. <em>J. Med Chem.</em><strong>66</strong>, 11094â€“11117 (2023).
</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.3c00465" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37584263/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deng,%20X.%20et%20al.%20Identification%20of%20Novel%20Dual-Target%20Estrogen%20Receptor%20%CE%B1%20Degraders%20with%20Tubulin%20inhibitory%20activity%20for%20the%20treatment%20of%20endocrine-resistant%20breast%20cancer.%20J.%20Med%20Chem.66,%2011094%E2%80%9311117%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Zhao, W. et al. Ginsenoside Rg3 overcomes tamoxifen resistance through inhibiting glycolysis in breast cancer cells. <em>Cell Biol. Int</em>. <strong>48</strong>, 496â€“509 (2024).
</cite> [<a href="https://doi.org/10.1002/cbin.12123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38225685/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao,%20W.%20et%20al.%20Ginsenoside%20Rg3%20overcomes%20tamoxifen%20resistance%20through%20inhibiting%20glycolysis%20in%20breast%20cancer%20cells.%20Cell%20Biol.%20Int.%2048,%20496%E2%80%93509%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Yuan, J. et al. Tinagl1 restores tamoxifen sensitivity and blocks fibronectin-induced EMT by simultaneously blocking the EGFR and Î²1-integrin/FAK signaling pathways in tamoxifen-resistant breast cancer cells. <em>IUBMB Life</em><strong>77</strong>, e2940 (2025).
</cite> [<a href="https://doi.org/10.1002/iub.2940" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39817673/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yuan,%20J.%20et%20al.%20Tinagl1%20restores%20tamoxifen%20sensitivity%20and%20blocks%20fibronectin-induced%20EMT%20by%20simultaneously%20blocking%20the%20EGFR%20and%20%CE%B21-integrin/FAK%20signaling%20pathways%20in%20tamoxifen-resistant%20breast%20cancer%20cells.%20IUBMB%20Life77,%20e2940%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Kumar, N. et al. Most recent strategies targeting estrogen receptor alpha for the treatment of breast cancer. <em>Mol. Divers</em><strong>25</strong>, 603â€“624 (2021).
</cite> [<a href="https://doi.org/10.1007/s11030-020-10133-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32886304/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kumar,%20N.%20et%20al.%20Most%20recent%20strategies%20targeting%20estrogen%20receptor%20alpha%20for%20the%20treatment%20of%20breast%20cancer.%20Mol.%20Divers25,%20603%E2%80%93624%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Burstein, H. J. Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer reply. <em>Reply, N. Engl. J. Med</em>. <strong>384</strong>, 1176â€“1177 (2021).
</cite> [<a href="https://doi.org/10.1056/NEJMc2101282" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33761226/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Burstein,%20H.%20J.%20Systemic%20Therapy%20for%20Estrogen%20Receptor-Positive,%20HER2-Negative%20Breast%20Cancer%20reply.%20Reply,%20N.%20Engl.%20J.%20Med.%20384,%201176%E2%80%931177%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Zhou, J. et al. A novel selective estrogen receptor degrader induces cell cycle arrest in breast cancer via ERÎ± degradation and the autophagy-lysosome pathway. <em>Bioorg. Med. Chem.</em><strong>82</strong>, 117235 (2023).
</cite> [<a href="https://doi.org/10.1016/j.bmc.2023.117235" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36905762/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou,%20J.%20et%20al.%20A%20novel%20selective%20estrogen%20receptor%20degrader%20induces%20cell%20cycle%20arrest%20in%20breast%20cancer%20via%20ER%CE%B1%20degradation%20and%20the%20autophagy-lysosome%20pathway.%20Bioorg.%20Med.%20Chem.82,%20117235%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Zheng, Z. Z. et al. Super-enhancer-controlled positive feedback loop BRD4/ERÎ±-RET-ERÎ± promotes ERÎ±-positive breast cancer. <em>Nucleic Acids Res.</em><strong>50</strong>, 10230â€“10248 (2022).
</cite> [<a href="https://doi.org/10.1093/nar/gkac778" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9561272/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36124682/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng,%20Z.%20Z.%20et%20al.%20Super-enhancer-controlled%20positive%20feedback%20loop%20BRD4/ER%CE%B1-RET-ER%CE%B1%20promotes%20ER%CE%B1-positive%20breast%20cancer.%20Nucleic%20Acids%20Res.50,%2010230%E2%80%9310248%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Chen, X. S. et al. UCH-L1-mediated Down-regulation of Estrogen Receptor Î± Contributes to Insensitivity to Endocrine Therapy for Breast Cancer. <em>Theranostics</em><strong>10</strong>, 1833â€“1848 (2020).
</cite> [<a href="https://doi.org/10.7150/thno.39814" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6993235/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32042339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen,%20X.%20S.%20et%20al.%20UCH-L1-mediated%20Down-regulation%20of%20Estrogen%20Receptor%20%CE%B1%20Contributes%20to%20Insensitivity%20to%20Endocrine%20Therapy%20for%20Breast%20Cancer.%20Theranostics10,%201833%E2%80%931848%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Liu, S. et al. MCM2 is involved in subtyping and tamoxifen resistance of ERÎ±-positive breast cancer by acting as the downstream factor of ERÎ±,. <em>Biotechnol. J.</em><strong>19</strong>, e2300560 (2024).
</cite> [<a href="https://doi.org/10.1002/biot.202300560" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38403459/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu,%20S.%20et%20al.%20MCM2%20is%20involved%20in%20subtyping%20and%20tamoxifen%20resistance%20of%20ER%CE%B1-positive%20breast%20cancer%20by%20acting%20as%20the%20downstream%20factor%20of%20ER%CE%B1,.%20Biotechnol.%20J.19,%20e2300560%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Lai, X. et al., HGF/c-Met Promotes Breast Cancer Tamoxifen Resistance Through the EZH2/HOTAIR-miR-141/200a Feedback Signaling Pathway. <em>Mol. Carcinog.</em><strong>64</strong>, 769â€“783 (2025).</cite> [<a href="https://doi.org/10.1002/mc.23878" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39853766/" class="usa-link">PubMed</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Melone, V. et al. LncRNA PVT1 links estrogen receptor alpha and the polycomb repressive complex 2 in suppression of pro-apoptotic genes in hormone-responsive breast cancer. <em>Cell Death Dis.</em><strong>16</strong>, 80 (2025).
</cite> [<a href="https://doi.org/10.1038/s41419-025-07423-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11807188/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39922814/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Melone,%20V.%20et%20al.%20LncRNA%20PVT1%20links%20estrogen%20receptor%20alpha%20and%20the%20polycomb%20repressive%20complex%202%20in%20suppression%20of%20pro-apoptotic%20genes%20in%20hormone-responsive%20breast%20cancer.%20Cell%20Death%20Dis.16,%2080%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Heid, E. et al. Chemprop: A Machine Learning Package for Chemical Property Prediction. <em>J. Chem. Inf. Model</em><strong>64</strong>, 9â€“17 (2024).
</cite> [<a href="https://doi.org/10.1021/acs.jcim.3c01250" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10777403/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38147829/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Heid,%20E.%20et%20al.%20Chemprop:%20A%20Machine%20Learning%20Package%20for%20Chemical%20Property%20Prediction.%20J.%20Chem.%20Inf.%20Model64,%209%E2%80%9317%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Su, S., Dou, H., Wang, Z. &amp; Zhang, Q. Bufalin inhibits ovarian carcinoma via targeting mTOR/HIF-Î± pathway. <em>Basic Clin. Pharm. Toxicol.</em><strong>128</strong>, 224â€“233 (2021).</cite> [<a href="https://doi.org/10.1111/bcpt.13487" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32905663/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Su,%20S.,%20Dou,%20H.,%20Wang,%20Z.%20&amp;%20Zhang,%20Q.%20Bufalin%20inhibits%20ovarian%20carcinoma%20via%20targeting%20mTOR/HIF-%CE%B1%20pathway.%20Basic%20Clin.%20Pharm.%20Toxicol.128,%20224%E2%80%93233%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Yu, Z. et al. Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation. <em>Cell Oncol.</em><strong>43</strong>, 1129â€“1145 (2020).</cite> [<a href="https://doi.org/10.1007/s13402-020-00546-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32623699/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yu,%20Z.%20et%20al.%20Bufalin%20inhibits%20hepatitis%20B%20virus-associated%20hepatocellular%20carcinoma%20development%20through%20androgen%20receptor%20dephosphorylation%20and%20cell%20cycle-related%20kinase%20degradation.%20Cell%20Oncol.43,%201129%E2%80%931145%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Chen, R. Y. et al. Estradiol inhibits Th17 cell differentiation through inhibition of RORÎ³T transcription by recruiting the ERÎ±/REA complex to estrogen response elements of the RORÎ³T promoter. <em>J. Immunol.</em><strong>194</strong>, 4019â€“4028 (2015).
</cite> [<a href="https://doi.org/10.4049/jimmunol.1400806" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4390502/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25769926/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen,%20R.%20Y.%20et%20al.%20Estradiol%20inhibits%20Th17%20cell%20differentiation%20through%20inhibition%20of%20ROR%CE%B3T%20transcription%20by%20recruiting%20the%20ER%CE%B1/REA%20complex%20to%20estrogen%20response%20elements%20of%20the%20ROR%CE%B3T%20promoter.%20J.%20Immunol.194,%204019%E2%80%934028%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Casa, A. J., Hochbaum, D., Sreekumar, S., Oesterreich, S. &amp; Lee, A. V. The estrogen receptor alpha nuclear localization sequence is critical for fulvestrant-induced degradation of the receptor. <em>Mol. Cell Endocrinol.</em><strong>415</strong>, 76â€“86 (2015).
</cite> [<a href="https://doi.org/10.1016/j.mce.2015.08.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26272024/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Casa,%20A.%20J.,%20Hochbaum,%20D.,%20Sreekumar,%20S.,%20Oesterreich,%20S.%20&amp;%20Lee,%20A.%20V.%20The%20estrogen%20receptor%20alpha%20nuclear%20localization%20sequence%20is%20critical%20for%20fulvestrant-induced%20degradation%20of%20the%20receptor.%20Mol.%20Cell%20Endocrinol.415,%2076%E2%80%9386%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Yuan, L., Li, X., Yang, H. &amp; Li, H. The ubiquitin ligase RNF2 stabilizes ERÎ± and modulates breast cancer progression. <em>Hum. Cell</em><strong>36</strong>, 353â€“365 (2023).
</cite> [<a href="https://doi.org/10.1007/s13577-022-00810-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9813066/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36271315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yuan,%20L.,%20Li,%20X.,%20Yang,%20H.%20&amp;%20Li,%20H.%20The%20ubiquitin%20ligase%20RNF2%20stabilizes%20ER%CE%B1%20and%20modulates%20breast%20cancer%20progression.%20Hum.%20Cell36,%20353%E2%80%93365%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Zhu, J. et al. The ubiquitin ligase RNF181 stabilizes ERÎ± and modulates breast cancer progression. <em>Oncogene</em><strong>39</strong>, 6776â€“6788 (2020).
</cite> [<a href="https://doi.org/10.1038/s41388-020-01464-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7605433/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32973333/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhu,%20J.%20et%20al.%20The%20ubiquitin%20ligase%20RNF181%20stabilizes%20ER%CE%B1%20and%20modulates%20breast%20cancer%20progression.%20Oncogene39,%206776%E2%80%936788%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Xue, M. et al. Regulation of estrogen signaling and breast cancer proliferation by an ubiquitin ligase TRIM56. <em>Oncogenesis</em><strong>8</strong>, 30 (2019).
</cite> [<a href="https://doi.org/10.1038/s41389-019-0139-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6473003/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31000690/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xue,%20M.%20et%20al.%20Regulation%20of%20estrogen%20signaling%20and%20breast%20cancer%20proliferation%20by%20an%20ubiquitin%20ligase%20TRIM56.%20Oncogenesis8,%2030%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Fan, M., Park, A. &amp; Nephew, K. P. CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha. <em>Mol. Endocrinol.</em><strong>19</strong>, 2901â€“2914 (2005).
</cite> [<a href="https://doi.org/10.1210/me.2005-0111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16037132/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fan,%20M.,%20Park,%20A.%20&amp;%20Nephew,%20K.%20P.%20CHIP%20(carboxyl%20terminus%20of%20Hsc70-interacting%20protein)%20promotes%20basal%20and%20geldanamycin-induced%20degradation%20of%20estrogen%20receptor-alpha.%20Mol.%20Endocrinol.19,%202901%E2%80%932914%20(2005)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>McDonough, H. &amp; Patterson, C. CHIP: a link between the chaperone and proteasome systems. <em>Cell Stress Chaperones</em><strong>8</strong>, 303â€“308 (2003).
</cite> [<a href="https://doi.org/10.1379/1466-1268(2003)008&lt;0303:calbtc&gt;2.0.co;2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC514901/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15115282/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McDonough,%20H.%20&amp;%20Patterson,%20C.%20CHIP:%20a%20link%20between%20the%20chaperone%20and%20proteasome%20systems.%20Cell%20Stress%20Chaperones8,%20303%E2%80%93308%20(2003)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Luo, H., Liu, N. &amp; Lin, C. Dopamine enhances recovery after traumatic brain injury through ubiquitylation and autophagic degradation of RIPK1. <em>Cell Commun. Signal</em><strong>22</strong>, 134 (2024).
</cite> [<a href="https://doi.org/10.1186/s12964-024-01515-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10875858/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38374093/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Luo,%20H.,%20Liu,%20N.%20&amp;%20Lin,%20C.%20Dopamine%20enhances%20recovery%20after%20traumatic%20brain%20injury%20through%20ubiquitylation%20and%20autophagic%20degradation%20of%20RIPK1.%20Cell%20Commun.%20Signal22,%20134%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Shomali, M. et al. SAR439859, a Novel Selective Estrogen Receptor Degrader (SERD), demonstrates effective and broad antitumor activity in wild-type and mutant ER-Positive breast cancer models. <em>Mol. Cancer Ther.</em><strong>20</strong>, 250â€“262 (2021).
</cite> [<a href="https://doi.org/10.1158/1535-7163.MCT-20-0390" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33310762/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shomali,%20M.%20et%20al.%20SAR439859,%20a%20Novel%20Selective%20Estrogen%20Receptor%20Degrader%20(SERD),%20demonstrates%20effective%20and%20broad%20antitumor%20activity%20in%20wild-type%20and%20mutant%20ER-Positive%20breast%20cancer%20models.%20Mol.%20Cancer%20Ther.20,%20250%E2%80%93262%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Ye, Q. et al. An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives. <em>Front. Pharm.</em><strong>14</strong>, 1274336 (2023).</cite> [<a href="https://doi.org/10.3389/fphar.2023.1274336" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10582727/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37860119/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ye,%20Q.%20et%20al.%20An%20overview%20of%20the%20past%20decade%20of%20bufalin%20in%20the%20treatment%20of%20refractory%20and%20drug-resistant%20cancers:%20current%20status,%20challenges,%20and%20future%20perspectives.%20Front.%20Pharm.14,%201274336%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Zhang, Z., He, X., Long, D., Luo, G. &amp; Chen, S. Enhancing generalizability and performance in drug-target interaction identification by integrating pharmacophore and pre-trained models. <em>Bioinformatics</em><strong>40</strong>, i539â€“i547 (2024).
</cite> [<a href="https://doi.org/10.1093/bioinformatics/btae240" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11211825/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38940179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang,%20Z.,%20He,%20X.,%20Long,%20D.,%20Luo,%20G.%20&amp;%20Chen,%20S.%20Enhancing%20generalizability%20and%20performance%20in%20drug-target%20interaction%20identification%20by%20integrating%20pharmacophore%20and%20pre-trained%20models.%20Bioinformatics40,%20i539%E2%80%93i547%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Song, W., Xu, L., Han, C., Tian, Z. &amp; Zou, Q. Drug-target interaction predictions with multi-view similarity network fusion strategy and deep interactive attention mechanism. <em>Bioinformatics</em><strong>40</strong>, btae346 (2024).
</cite> [<a href="https://doi.org/10.1093/bioinformatics/btae346" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11164831/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38837345/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Song,%20W.,%20Xu,%20L.,%20Han,%20C.,%20Tian,%20Z.%20&amp;%20Zou,%20Q.%20Drug-target%20interaction%20predictions%20with%20multi-view%20similarity%20network%20fusion%20strategy%20and%20deep%20interactive%20attention%20mechanism.%20Bioinformatics40,%20btae346%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Lin, X., Li, X. &amp; Lin, X. A Review on Applications of Computational Methods in Drug Screening and Design. <em>Molecules</em><strong>25</strong>, 1375 (2020).
</cite> [<a href="https://doi.org/10.3390/molecules25061375" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7144386/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32197324/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin,%20X.,%20Li,%20X.%20&amp;%20Lin,%20X.%20A%20Review%20on%20Applications%20of%20Computational%20Methods%20in%20Drug%20Screening%20and%20Design.%20Molecules25,%201375%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Jiang, S. L. et al. Tubeimoside-1, a triterpenoid saponin, induces cytoprotective autophagy in human breast cancer cells in vitro via Akt-mediated pathway. <em>Acta Pharm. Sin.</em><strong>40</strong>, 919â€“928 (2019).</cite> [<a href="https://doi.org/10.1038/s41401-018-0165-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6786367/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30315250/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiang,%20S.%20L.%20et%20al.%20Tubeimoside-1,%20a%20triterpenoid%20saponin,%20induces%20cytoprotective%20autophagy%20in%20human%20breast%20cancer%20cells%20in%20vitro%20via%20Akt-mediated%20pathway.%20Acta%20Pharm.%20Sin.40,%20919%E2%80%93928%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Guan, Y. et al. Combined treatment of mitoxantrone sensitizes breast cancer cells to rapalogs through blocking eEF-2K-mediated activation of Akt and autophagy. <em>Cell Death Dis.</em><strong>11</strong>, 948 (2020).
</cite> [<a href="https://doi.org/10.1038/s41419-020-03153-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7642277/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33144562/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guan,%20Y.%20et%20al.%20Combined%20treatment%20of%20mitoxantrone%20sensitizes%20breast%20cancer%20cells%20to%20rapalogs%20through%20blocking%20eEF-2K-mediated%20activation%20of%20Akt%20and%20autophagy.%20Cell%20Death%20Dis.11,%20948%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Wang, T. et al. The effects of bufadienolides on HER2 overexpressing breast cancer cells. <em>Tumour Biol.</em><strong>37</strong>, 7155â€“7163 (2016).
</cite> [<a href="https://doi.org/10.1007/s13277-015-4381-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26662961/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang,%20T.%20et%20al.%20The%20effects%20of%20bufadienolides%20on%20HER2%20overexpressing%20breast%20cancer%20cells.%20Tumour%20Biol.37,%207155%E2%80%937163%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Wu, S. et al. Bufalin induces ferroptosis by modulating the 2,4-dienoyl-CoA reductase (DECR1)-SLC7A11 axis in breast cancer. <em>Phytomedicine</em><strong>135</strong>, 156130 (2024).
</cite> [<a href="https://doi.org/10.1016/j.phymed.2024.156130" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39427521/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu,%20S.%20et%20al.%20Bufalin%20induces%20ferroptosis%20by%20modulating%20the%202,4-dienoyl-CoA%20reductase%20(DECR1)-SLC7A11%20axis%20in%20breast%20cancer.%20Phytomedicine135,%20156130%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Li, C. et al. Bufalin Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Macrophage Pyroptosis via P62 Pathway. <em>J. Cardiovasc. Transl. Res.</em><strong>18</strong>, 221â€“236 (2024).</cite> [<a href="https://doi.org/10.1007/s12265-024-10577-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12043737/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39733202/" class="usa-link">PubMed</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Zheng, Y. D. et al. Bufalin induces apoptosis and autophagy via the Ca2+/CaMKKÎ²/AMPK/Beclin1 signaling pathway in osteosarcoma cells. <em>Cell Biol. Int</em>. <strong>47</strong>, 1344â€“1353 (2023).
</cite> [<a href="https://doi.org/10.1002/cbin.12021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36987947/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng,%20Y.%20D.%20et%20al.%20Bufalin%20induces%20apoptosis%20and%20autophagy%20via%20the%20Ca2+/CaMKK%CE%B2/AMPK/Beclin1%20signaling%20pathway%20in%20osteosarcoma%20cells.%20Cell%20Biol.%20Int.%2047,%201344%E2%80%931353%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Liu, X. D., Song, C. Y., Kong, C. C. &amp; Tian, X. Bufalin Induces Programmed Necroptosis in Triple-Negative Breast Cancer Drug-Resistant Cell Lines through RIP1/ROS-Mediated Pathway. <em>Chin. J. Integr. Med</em>. <strong>28</strong>, 900â€“908 (2022).
</cite> [<a href="https://doi.org/10.1007/s11655-021-3458-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34826043/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu,%20X.%20D.,%20Song,%20C.%20Y.,%20Kong,%20C.%20C.%20&amp;%20Tian,%20X.%20Bufalin%20Induces%20Programmed%20Necroptosis%20in%20Triple-Negative%20Breast%20Cancer%20Drug-Resistant%20Cell%20Lines%20through%20RIP1/ROS-Mediated%20Pathway.%20Chin.%20J.%20Integr.%20Med.%2028,%20900%E2%80%93908%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Zhang, Y. et al. Role of P53-Senescence induction in suppression of LNCaP prostate cancer growth by cardiotonic compound bufalin. <em>Mol. Cancer Ther.</em><strong>17</strong>, 2341â€“2352 (2018).
</cite> [<a href="https://doi.org/10.1158/1535-7163.MCT-17-1296" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6668018/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30166403/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang,%20Y.%20et%20al.%20Role%20of%20P53-Senescence%20induction%20in%20suppression%20of%20LNCaP%20prostate%20cancer%20growth%20by%20cardiotonic%20compound%20bufalin.%20Mol.%20Cancer%20Ther.17,%202341%E2%80%932352%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Liu, T. et al. Bufalin inhibits cellular proliferation and cancer stem cell-like phenotypes via upregulation of MiR-203 in Glioma. <em>Cell Physiol. Biochem</em>. <strong>44</strong>, 671â€“681 (2017).
</cite> [<a href="https://doi.org/10.1159/000485279" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29169175/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu,%20T.%20et%20al.%20Bufalin%20inhibits%20cellular%20proliferation%20and%20cancer%20stem%20cell-like%20phenotypes%20via%20upregulation%20of%20MiR-203%20in%20Glioma.%20Cell%20Physiol.%20Biochem.%2044,%20671%E2%80%93681%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Chen, P., Li, B. &amp; Ou-Yang, L. Role of estrogen receptors in health and disease. <em>Front Endocrinol.</em><strong>13</strong>, 839005 (2022).</cite> [<a href="https://doi.org/10.3389/fendo.2022.839005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9433670/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36060947/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen,%20P.,%20Li,%20B.%20&amp;%20Ou-Yang,%20L.%20Role%20of%20estrogen%20receptors%20in%20health%20and%20disease.%20Front%20Endocrinol.13,%20839005%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Bak, M. J., Das Gupta, S., Wahler, J. &amp; Suh, N. Role of dietary bioactive natural products in estrogen receptor-positive breast cancer. <em>Semin Cancer Biol.</em><strong>40-41</strong>, 170â€“191 (2016).
</cite> [<a href="https://doi.org/10.1016/j.semcancer.2016.03.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5033666/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27016037/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bak,%20M.%20J.,%20Das%20Gupta,%20S.,%20Wahler,%20J.%20&amp;%20Suh,%20N.%20Role%20of%20dietary%20bioactive%20natural%20products%20in%20estrogen%20receptor-positive%20breast%20cancer.%20Semin%20Cancer%20Biol.40-41,%20170%E2%80%93191%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Wang, Y. et al. Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer. <em>Acta Pharm. Sin. B.</em><strong>13</strong>, 4963â€“4982 (2023).
</cite> [<a href="https://doi.org/10.1016/j.apsb.2023.05.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10692362/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38045063/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang,%20Y.%20et%20al.%20Discovery%20of%20novel%20covalent%20selective%20estrogen%20receptor%20degraders%20against%20endocrine-resistant%20breast%20cancer.%20Acta%20Pharm.%20Sin.%20B.13,%204963%E2%80%934982%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>BÃ©kÃ©s, M., Langley, D. R. &amp; Crews, C. M. PROTAC targeted protein degraders: the past is prologue. <em>Nat. Rev. Drug Discov.</em><strong>21</strong>, 181â€“200 (2022).
</cite> [<a href="https://doi.org/10.1038/s41573-021-00371-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8765495/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35042991/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?B%C3%A9k%C3%A9s,%20M.,%20Langley,%20D.%20R.%20&amp;%20Crews,%20C.%20M.%20PROTAC%20targeted%20protein%20degraders:%20the%20past%20is%20prologue.%20Nat.%20Rev.%20Drug%20Discov.21,%20181%E2%80%93200%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Lemaitre, T. et al. Molecular glue degraders: exciting opportunities for novel drug discovery. <em>Expert Opin. Drug Discov.</em><strong>19</strong>, 433â€“449 (2024).</cite> [<a href="https://doi.org/10.1080/17460441.2024.2306845" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38240114/" class="usa-link">PubMed</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Schreiber, S. L. The Rise of Molecular Glues. <em>Cell</em><strong>184</strong>, 3â€“9 (2021).
</cite> [<a href="https://doi.org/10.1016/j.cell.2020.12.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33417864/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schreiber,%20S.%20L.%20The%20Rise%20of%20Molecular%20Glues.%20Cell184,%203%E2%80%939%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Liu, T. T. et al. Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy. <em>EBioMedicine</em><strong>86</strong>, 104353 (2022).
</cite> [<a href="https://doi.org/10.1016/j.ebiom.2022.104353" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9667253/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36375317/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu,%20T.%20T.%20et%20al.%20Atypical%20E3%20ligase%20ZFP91%20promotes%20small-molecule-induced%20E2F2%20transcription%20factor%20degradation%20for%20cancer%20therapy.%20EBioMedicine86,%20104353%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Zhu, J. et al. Involvement of RFC3 in tamoxifen resistance in ER-positive breast cancer through the cell cycle. <em>Aging</em><strong>15</strong>, 13738â€“13752 (2023).
</cite> [<a href="https://doi.org/10.18632/aging.205260" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10756131/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38059884/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhu,%20J.%20et%20al.%20Involvement%20of%20RFC3%20in%20tamoxifen%20resistance%20in%20ER-positive%20breast%20cancer%20through%20the%20cell%20cycle.%20Aging15,%2013738%E2%80%9313752%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Song, T. et al. Small molecule inhibitor targeting the Hsp70-Bim protein-protein interaction in estrogen receptor-positive breast cancer overcomes tamoxifen resistance. <em>Breast Cancer Res.</em><strong>26</strong>, 33 (2024).
</cite> [<a href="https://doi.org/10.1186/s13058-024-01790-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10895875/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38409088/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Song,%20T.%20et%20al.%20Small%20molecule%20inhibitor%20targeting%20the%20Hsp70-Bim%20protein-protein%20interaction%20in%20estrogen%20receptor-positive%20breast%20cancer%20overcomes%20tamoxifen%20resistance.%20Breast%20Cancer%20Res.26,%2033%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Hanker, A. B., Sudhan, D. R. &amp; Arteaga, C. L. Overcoming endocrine resistance in breast cancer. <em>Cancer Cell</em><strong>37</strong>, 496â€“513 (2020).
</cite> [<a href="https://doi.org/10.1016/j.ccell.2020.03.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7169993/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32289273/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hanker,%20A.%20B.,%20Sudhan,%20D.%20R.%20&amp;%20Arteaga,%20C.%20L.%20Overcoming%20endocrine%20resistance%20in%20breast%20cancer.%20Cancer%20Cell37,%20496%E2%80%93513%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Lu, Y. &amp; Liu, W. Selective Estrogen Receptor Degraders (SERDs): A promising strategy for estrogen receptor positive endocrine-resistant breast cancer. <em>J. Med Chem.</em><strong>63</strong>, 15094â€“15114 (2020).
</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.0c00913" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33138369/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lu,%20Y.%20&amp;%20Liu,%20W.%20Selective%20Estrogen%20Receptor%20Degraders%20(SERDs):%20A%20promising%20strategy%20for%20estrogen%20receptor%20positive%20endocrine-resistant%20breast%20cancer.%20J.%20Med%20Chem.63,%2015094%E2%80%9315114%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Xie, B. et al. Discovery of a novel class of PROTACs as potent and selective estrogen receptor Î± degraders to overcome endocrine-resistant breast cancer in vitro and in vivo. <em>J. Med Chem.</em><strong>66</strong>, 6631â€“6651 (2023).
</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.2c02032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37161783/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xie,%20B.%20et%20al.%20Discovery%20of%20a%20novel%20class%20of%20PROTACs%20as%20potent%20and%20selective%20estrogen%20receptor%20%CE%B1%20degraders%20to%20overcome%20endocrine-resistant%20breast%20cancer%20in%20vitro%20and%20in%20vivo.%20J.%20Med%20Chem.66,%206631%E2%80%936651%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Deng, X. et al. Discovery of novel bicyclic phenylselenyl-containing hybrids: an orally bioavailable, potential, and multiacting class of estrogen receptor modulators against endocrine-resistant breast cancer. <em>J. Med Chem.</em><strong>65</strong>, 7993â€“8010 (2022).
</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.2c00525" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35611405/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deng,%20X.%20et%20al.%20Discovery%20of%20novel%20bicyclic%20phenylselenyl-containing%20hybrids:%20an%20orally%20bioavailable,%20potential,%20and%20multiacting%20class%20of%20estrogen%20receptor%20modulators%20against%20endocrine-resistant%20breast%20cancer.%20J.%20Med%20Chem.65,%207993%E2%80%938010%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Shiau, A. K. et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. <em>Cell</em><strong>95</strong>, 927â€“937 (1998).
</cite> [<a href="https://doi.org/10.1016/s0092-8674(00)81717-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9875847/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shiau,%20A.%20K.%20et%20al.%20The%20structural%20basis%20of%20estrogen%20receptor/coactivator%20recognition%20and%20the%20antagonism%20of%20this%20interaction%20by%20tamoxifen.%20Cell95,%20927%E2%80%93937%20(1998)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Ã“ ConchÃºir, S. et al. A web resource for standardized benchmark datasets, metrics, and rosetta protocols for macromolecular modeling and design. <em>PLoS One</em>. <strong>10</strong>, e0130433 (2015).
</cite> [<a href="https://doi.org/10.1371/journal.pone.0130433" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4559433/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26335248/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?%C3%93%20Conch%C3%BAir,%20S.%20et%20al.%20A%20web%20resource%20for%20standardized%20benchmark%20datasets,%20metrics,%20and%20rosetta%20protocols%20for%20macromolecular%20modeling%20and%20design.%20PLoS%20One.%2010,%20e0130433%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Alekseenko, A., Ignatov, M., Jones, G., Sabitova, M. &amp; Kozakov, D. Protein-protein and protein-peptide docking with ClusPro server. <em>Methods Mol. Biol.</em><strong>2165</strong>, 157â€“174 (2020).
</cite> [<a href="https://doi.org/10.1007/978-1-0716-0708-4_9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32621224/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alekseenko,%20A.,%20Ignatov,%20M.,%20Jones,%20G.,%20Sabitova,%20M.%20&amp;%20Kozakov,%20D.%20Protein-protein%20and%20protein-peptide%20docking%20with%20ClusPro%20server.%20Methods%20Mol.%20Biol.2165,%20157%E2%80%93174%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Tian, C. et al. ff19SB: Amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. <em>J. Chem. Theory Comput</em>. <strong>16</strong>, 528â€“552 (2020).
</cite> [<a href="https://doi.org/10.1021/acs.jctc.9b00591" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31714766/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tian,%20C.%20et%20al.%20ff19SB:%20Amino-acid-specific%20protein%20backbone%20parameters%20trained%20against%20quantum%20mechanics%20energy%20surfaces%20in%20solution.%20J.%20Chem.%20Theory%20Comput.%2016,%20528%E2%80%93552%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A. &amp; Case, D. A. Development and testing of a general amber force field. <em>J. Comput Chem.</em><strong>25</strong>, 1157â€“1174 (2004).
</cite> [<a href="https://doi.org/10.1002/jcc.20035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15116359/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang,%20J.,%20Wolf,%20R.%20M.,%20Caldwell,%20J.%20W.,%20Kollman,%20P.%20A.%20&amp;%20Case,%20D.%20A.%20Development%20and%20testing%20of%20a%20general%20amber%20force%20field.%20J.%20Comput%20Chem.25,%201157%E2%80%931174%20(2004)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Case, D. A. et al. AmberTools. <em>J. Chem. Inf. Model</em><strong>63</strong>, 6183â€“6191 (2023).
</cite> [<a href="https://doi.org/10.1021/acs.jcim.3c01153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10598796/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37805934/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Case,%20D.%20A.%20et%20al.%20AmberTools.%20J.%20Chem.%20Inf.%20Model63,%206183%E2%80%936191%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Miller, B. R. 3rd et al. MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. <em>J. Chem. Theory Comput</em>. <strong>8</strong>, 3314â€“3321 (2012).
</cite> [<a href="https://doi.org/10.1021/ct300418h" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26605738/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Miller,%20B.%20R.%203rd%20et%20al.%20MMPBSA.py:%20An%20Efficient%20Program%20for%20End-State%20Free%20Energy%20Calculations.%20J.%20Chem.%20Theory%20Comput.%208,%203314%E2%80%933321%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Wan, X. et al. Identification of a Novel Substrate for eEF2K and the AURKA-SOX8 as the Related Pathway in TNBC. <em>Adv. Sci.</em><strong>12</strong>, e2412985 (2025).</cite> [<a href="https://doi.org/10.1002/advs.202412985" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11984844/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39950798/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wan,%20X.%20et%20al.%20Identification%20of%20a%20Novel%20Substrate%20for%20eEF2K%20and%20the%20AURKA-SOX8%20as%20the%20Related%20Pathway%20in%20TNBC.%20Adv.%20Sci.12,%20e2412985%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>Jiang, T. et al. Targeting lncRNA DDIT4-AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy. <em>Adv. Sci.</em><strong>10</strong>, e2207257 (2023).</cite> [<a href="https://doi.org/10.1002/advs.202207257" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10265098/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37096846/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiang,%20T.%20et%20al.%20Targeting%20lncRNA%20DDIT4-AS1%20Sensitizes%20Triple%20Negative%20Breast%20Cancer%20to%20Chemotherapy%20via%20Suppressing%20of%20Autophagy.%20Adv.%20Sci.10,%20e2207257%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Gong R. et al. GPX4-AUTAC induces ferroptosis in breast cancer by promoting the selective autophagic degradation of GPX4 mediated by TRAF6-p62, <em>C</em><em>ell Death Differ.</em>10.1038/s41418-025-01528-1. Online ahead of print (2025).</cite> [<a href="https://doi.org/10.1038/s41418-025-01528-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40394165/" class="usa-link">PubMed</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373995/bin/41467_2025_62288_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Information</a><sup> (305.2KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373995/bin/41467_2025_62288_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Reporting Summary</a><sup> (3.5MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373995/bin/41467_2025_62288_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Transparent Peer Review file</a><sup> (446.6KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373995/bin/41467_2025_62288_MOESM4_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Source Data</a><sup> (3.1MB, xlsx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>All data are included within the article, supplementary information or source data file.Â <a href="#Sec39" class="usa-link">Source data</a> are provided with this paper.</p>
<p>The code has been made available on GitHub (<a href="https://github.com/wei-xiao-ya/multi_task-NN" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/wei-xiao-ya/multi_task-NN</a>, <a href="https://github.com/LiHui-CADD/pro1-pro2-lig/tree/master" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/LiHui-CADD/pro1-pro2-lig/tree/master</a>). The molecular docking and MD simulation data are available in the â€œInputFileâ€ and â€œcodeâ€ sections, respectively, at <a href="https://github.com/LiHui-CADD/pro1-pro2-lig/tree/master" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/LiHui-CADD/pro1-pro2-lig/tree/master</a>.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Nature Communications are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s41467-025-62288-7"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41467_2025_Article_62288.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (4.7Â MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12373995/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12373995/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12373995%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373995/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12373995/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12373995/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40846852/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12373995/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40846852/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12373995/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12373995/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="58RxpWziWcdKkwWidkPzDdtcZljg3bZj73OTKQYCrKTXAL81nLXeADOhFJt3NJoc">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
